0001104659-20-125040.txt : 20201113 0001104659-20-125040.hdr.sgml : 20201113 20201113160126 ACCESSION NUMBER: 0001104659-20-125040 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 47 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201113 DATE AS OF CHANGE: 20201113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DFP HEALTHCARE ACQUISITIONS CORP. CENTRAL INDEX KEY: 0001799191 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39248 FILM NUMBER: 201311364 BUSINESS ADDRESS: STREET 1: 780 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (212) 551-1600 MAIL ADDRESS: STREET 1: 780 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 10-Q 1 tm2029632d1_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

DFP HEALTHCARE ACQUISITIONS CORP.

(Exact name of registrant as specified in its charter)

Delaware		001-39248		84-3562323
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

780 Third Avenue, 37^thFloor

New York, New York 10017

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (212) 551-1600

Not Applicable
(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant	DFPHU	The Nasdaq Stock Market LLC
Class A common stock, par value $0.0001 per share	DFPH	The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share	DFPHW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	x	Smaller reporting company	x
		Emerging growth company	x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes x No ¨

As of November 13, 2020, 23,000,000 shares of Class A common stock, par value $0.0001, and 5,750,000 shares of Class B common stock, par value $0.0001, were issued and outstanding.

DFP HEALTHCARE ACQUISITIONS CORP.

Quarterly Report on Form 10-Q

Table of Contents

			Page No.
	PART I. FINANCIAL INFORMATION			1

Item 1.		Financial Statements		1

		Condensed Balance Sheets as of September 30, 2020 (Unaudited) and December 31, 2019		1

		Unaudited Condensed Statements of Operations for the Three and Nine Months ended September 30, 2020		2

		Unaudited Condensed Statements of Changes in Stockholders’ Equity for the Three and Nine months Ended September 30, 2020		3

		Unaudited Condensed Statement of Cash Flows for the Nine Months Ended September 30, 2020		4

		Notes to Unaudited Condensed Financial Statements		5

Item 2.		Management’s Discussion and Analysis of Financial Condition and Results of Operations		15

Item 3.		Quantitative and Qualitative Disclosures About Market Risk		20

Item 4.		Controls and Procedures		20

	PART II. OTHER INFORMATION			20

Item 1.		Legal Proceedings		20

Item 1A.		Risk Factors		20

Item 2.		Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities		21

Item 3.		Defaults Upon Senior Securities		21

Item 4.		Mine Safety Disclosures		21

Item 5.		Other Information		21

Item 6.		Exhibits		22

SIGNATURES				23

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

DFP HEALTHCARE ACQUISITIONS CORP.

CONDENSED BALANCE SHEETS

	September 30, 2020			December 31, 2019
	(unaudited)
Assets:
Current assets:
Cash	$	998,571		$	25,000
Prepaid expenses		202,187			-
Total current assets		1,200,758			25,000
Cash and investments held in Trust Account		230,194,901			-
Deferred offering costs associated with initial public offering		-			25,000
Total assets	$	231,395,659		$	50,000

Liabilities and Stockholders' Equity:
Current liabilities:
Accounts payable	$	1,329		$	-
Accrued expenses		28,000			26,500
Accrued expenses - related parties		17,500			-
Franchise tax payable		150,100			800
Total current liabilities		196,929			27,300
Deferred underwriting commissions		6,300,000			-
Total liabilities		6,496,929			27,300

Commitments and Contingencies
Class A common stock, 21,989,872 and -0- shares subject to possible redemption at $10.00 per share at September 30, 2020 and December 31, 2019, respectively		219,898,720			-

Stockholders' Equity:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		-			-
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 1,010,128 and -0- shares issued and outstanding (excluding 21,989,872 and -0- shares subject to possible redemption) at September 30, 2020 and December 31, 2019, respectively		101			-
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 5,750,000 shares issued and outstanding at September 30, 2020 and December 31, 2019		575			575
Additional paid-in capital		5,300,118			24,425
Accumulated deficit		(300,784	)		(2,300	)
Total stockholders' equity		5,000,010			22,700
Total liabilities and stockholders' equity	$	231,395,659		$	50,000

The accompanying notes are an integral part of these unaudited condensed financial statements

DFP HEALTHCARE ACQUISITIONS CORP.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

	For the Three Months Ended September 30, 2020			For the Nine Months Ended September 30, 2020
General and administrative expenses	$	95,980		$	208,562
General and administrative expenses - related party		52,500			122,500
Franchise tax expense		50,000			149,750
Loss from operations		(198,480	)		(480,812	)
Interest income from investments in Trust Account		73,393			194,901
Loss before income tax expense		(125,087	)		(285,911	)
Income tax expense		12,573			12,573
Net loss	$	(137,660	)	$	(298,484	)

Weighted average shares outstanding of Class A common stock		23,000,000			23,000,000
Basic and diluted net income per share, Class A common stock	$	-		$	-
Weighted average shares outstanding of Class B common stock		5,750,000			5,750,000
Basic and diluted net loss per share, Class B common stock	$	(0.02	)	$	(0.05	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

DFP HEALTHCARE ACQUISITIONS CORP.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(UNAUDITED)

	For the Three and Nine Months Ended September 30, 2020
	Common Stock																Total
	Class A						Class B				Additional Paid-In			Accumulated			Stockholders'
	Shares			Amount			Shares		Amount		Capital			Deficit			Equity
Balance - December 31, 2019		-		$	-			5,750,000	$	575	$	24,425		$	(2,300	)	$	22,700
Sale of units in initial public offering		23,000,000			2,300			-		-		229,997,700			-			230,000,000
Offering costs		-			-			-		-		(10,425,486	)		-			(10,425,486	)
Sale of private placement warrants to Sponsor in private placement		-			-			-		-		5,600,000			-			5,600,000
Common stock subject to possible redemption		(22,015,212	)		(2,202	)		-		-		(220,149,918	)		-			(220,152,120	)
Net loss		-			-			-		-		-			(45,089	)		(45,089	)
Balance - March 31, 2020 (unaudited)		984,788		$	98			5,750,000	$	575	$	5,046,721		$	(47,389	)	$	5,000,005
Common stock subject to possible redemption		11,574			2			-		-		115,738			-			115,740
Net loss		-			-			-		-		-			(115,735	)		(115,735	)
Balance - June 30, 2020 (unaudited)		996,362		$	100			5,750,000	$	575	$	5,162,459		$	(163,124	)	$	5,000,010
Common stock subject to possible redemption		13,766			1			-		-		137,659			-			137,660
Net loss		-			-			-		-		-			(137,660	)		(137,660	)
Balance - September 30, 2020 (unaudited)		1,010,128		$	101			5,750,000	$	575	$	5,300,118		$	(300,784	)	$	5,000,010

The accompanying notes are an integral part of these unaudited condensed financial statements.

DFP HEALTHCARE ACQUISITIONS CORP.

CONDENSED STATEMENT OF CASH FLOWS

For the Nine Months Ended September 30, 2020

(UNAUDITED)

Cash Flows from Operating Activities:
Net loss	$	(298,484	)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on investments held in Trust Account		(194,901	)
Changes in operating assets and liabilities:
Prepaid expenses		(202,187	)
Accounts payable		1,329
Accrued expenses		26,500
Accrued expenses - related parties		17,500
Franchise tax payable		149,300
Net cash used in operating activities		(500,943	)

Cash Flows from Investing Activities
Principal deposited in Trust Account		(230,000,000	)
Net cash used in investing activities		(230,000,000	)

Cash Flows from Financing Activities:
Proceeds received from note payable to related party		200,000
Repayment of note payable to related party		(200,000	)
Proceeds received from initial public offering, gross		230,000,000
Proceeds received from private placement		5,600,000
Offering costs paid		(4,125,486	)
Net cash provided by financing activities		231,474,514

Net increase in cash		973,571

Cash - beginning of the period		25,000
Cash - end of the period	$	998,571

Supplemental disclosure of noncash activities:
Deferred underwriting commissions in connection with the initial public offering	$	6,300,000
Initial value of Class A common stock subject to possible redemption	$	220,164,430
Change in value of Class A common stock subject to possible redemption	$	(265,710	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

DFP HEALTHCARE ACQUISITIONS CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

1. Organization, Business Operations and Basis of Presentation.

Incorporation

DFP Healthcare Acquisitions Corp. (the “Company”) was incorporated as a Delaware corporation on November 1, 2019.

Sponsor

The Company's sponsor is DFP Sponsor LLC, a Delaware limited liability company (the “Sponsor”).

Fiscal Year End

The Company has selected December 31 as its fiscal year end.

Business Purpose

The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more operating businesses that it has not yet selected (“Business Combination”). The Company has neither engaged in any operations nor generated revenue to date.

As of September 30, 2020, the Company had not commenced any operations. All activity for the period from November 1, 2019 (inception) through September 30, 2020 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and since the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering.

The Company's management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering, although substantially all of the net proceeds of the Initial Public Offering are intended to be generally applied toward completing a Business Combination. Furthermore, there is no assurance that the Company will be able to successfully complete a Business Combination.

Financing

The registration statement for the Company’s Initial Public Offering was declared effective by the Securities and Exchange Commission (the “SEC”) on March 10, 2020. On March 13, 2020, the Company consummated its Initial Public Offering of 23,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), including 3,000,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $10.4 million, inclusive of approximately $6.3 million in deferred underwriting commissions (Note 3).

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 3,733,334 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor, generating proceeds of $5.6 million (Note 4).

Trust Account

Upon the closing of the Initial Public Offering and the Private Placement, $230.00 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (the “Trust Account”) and invested in permitted United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, which the Company refers to as the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act that invest only in direct U.S. government treasury obligations.

The Company's second amended and restated certificate of incorporation provides that, other than the withdrawal of interest earned on the funds that may be released to the Company to pay taxes, none of the funds held in Trust Account will be released until the earlier of: (i) the completion of the Business Combination; (ii) the redemption of the Public Shares to its holders (the “Public Stockholders”) properly tendered in connection with a stockholder vote to amend the Company's second amended and restated certificate of incorporation to modify the substance or timing of the Company's obligation to redeem 100% of the Public Shares or with respect to any other material provision relating to stockholders' rights or pre-initial Business Combination activity, or (iii) the redemption of 100% of the Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering.

DFP HEALTHCARE ACQUISITIONS CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

The Company, after signing a definitive agreement for a Business Combination, will either (i) seek stockholder approval of the Business Combination at a meeting called for such purpose in connection with which stockholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to fund its working capital requirements (subject to an annual limit of $500,000) and/or to pay its taxes, or (ii) provide the Public Stockholders with the opportunity to sell their shares to the Company by means of a tender offer for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to commencement of the tender offer, including interest earned on the funds held in the Trust Account and not previously released to the Company to fund its working capital requirements (subject to an annual limit of $500,000) and/or to pay taxes. The decision as to whether the Company will seek stockholder approval of the Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the outstanding shares of common stock voted are voted in favor of the Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001.

If the Company holds a stockholder vote in connection with a Business Combination, a Public Stockholder will have the right to redeem its shares for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to fund its working capital requirements (subject to an annual limit of $500,000) and/or to pay its taxes. As a result, such common stock is recorded at redemption amount and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with FASB, ASC 480, “Distinguishing Liabilities from Equity.” The amount in the Trust Account is initially anticipated to be $10.00 per public share ($230.0 million held in the Trust Account divided by 23,000,000 public shares).

The Company will have 24 months from the closing of the Initial Public Offering, or until March 13, 2022, to complete its initial Business Combination (the “Combination Period”). If the Company does not complete a Business Combination within this period of time, it will (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares for a per share pro rata portion of the Trust Account, including interest and not previously released to the Company to fund its working capital requirements (subject to an annual limit of $500,000) (less taxes payable and up to $100,000 of such net interest to pay dissolution expenses) and (iii) as promptly as possible following such redemption, liquidate and dissolve the balance of the Company's net assets to its remaining stockholders, as part of its plan of dissolution and liquidation. The Sponsor and the Company's officers and directors (the “initial stockholders”) have entered into a letter agreement with the Company, pursuant to which they have waived their rights to participate in any redemption with respect to their Founder Shares (as defined below); however, if the initial stockholders acquire shares of common stock in or after the Initial Public Offering, they will be entitled to a pro rata share of the Trust Account upon the Company's redemption of common stock or liquidation in the event the Company does not complete a Business Combination within the required time period. In the event of such a liquidating distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial price per Unit in the Initial Public Offering.

Basis of Presentation

The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected through December 31, 2020 or any future period.

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the final prospectus and the Form 8-K filed by the Company with the SEC on March 12, 2020 and March 19, 2020, respectively.

DFP HEALTHCARE ACQUISITIONS CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company's financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accountant standards used.

Liquidity

As of September 30, 2020, the Company had approximately $1.0 million in its operating bank account, working capital of approximately $1.0 million, and approximately $195,000 of interest income available in the Trust Account for working capital requirements (subject to an annual limit of $500,000) and/or to pay for the Company’s tax obligations, if any.

The Company’s liquidity needs to date have been satisfied through a $25,000 contribution from the Sponsor in exchange for the issuance of the Founder Shares to the Sponsor, the Note (defined below) of $200,000 from the Sponsor, and the proceeds from the consummation of the Private Placement not held in the Trust Account. On March 13, 2020, the Company repaid the Note in full to the Sponsor. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company with Working Capital Loans (see Note 4). As of September 30, 2020, there were no Working Capital Loans outstanding.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

2. Significant Accounting Policies.

Use of Estimates

The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future conforming events. Accordingly, the actual results could differ from those estimates.

DFP HEALTHCARE ACQUISITIONS CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2020 and December 31, 2019.

Investments Held in Trust Account

The Company’s portfolio of marketable securities is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the unaudited condensed balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain from investments held in the Trust Account in the accompanying unaudited condensed statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Fair Value of Financial Instruments

Fair value is defined as the price that would be received for sale of an asset, or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

As of September 30, 2020 and December 31, 2019, the carrying values of cash, accounts payable, accrued expenses, and tax obligations approximate their fair values due to the short-term nature of the instruments. The Company’s portfolio of marketable securities held in the Trust Account is comprised mainly of investments in U.S. Treasury securities with an original maturity of 185 days or less. The fair value for trading securities is determined using quoted market prices in active markets.

Offering Costs

The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering, and were charged to stockholders’ equity upon the completion of the Initial Public Offering.

DFP HEALTHCARE ACQUISITIONS CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Class A Common Stock Subject to Possible Redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2020 and December 31, 2019, 21,989,872 and -0- shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets, respectively.

Net Loss Per Share of Common Stock

Net loss per share is computed by dividing net loss by the weighted-average number of common stock outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 9,483,334 of the Company’s Class A common stock in the calculation of diluted income per share, since their inclusion would be anti-dilutive under the treasury stock method.

The Company’s unaudited condensed statements of operations include a presentation of loss per share for common stock subject to redemption in a manner similar to the two-class method of income (loss) per share. Net loss per common stock, basic and diluted for Class A common stock are calculated by dividing the interest income earned on the investments held in the Trust Account of approximately $74,000 and $195,000, less approximately $63,000 and $162,000 of maximum allowance for tax obligations, minus approximately $11,000 and $33,000 for working capital allowance, resulting in no income for Class A common stock for the three and nine months ended September 30, 2020, respectively, by the weighted average number of Class A common stock outstanding for the periods. Net loss per common stock, basic and diluted for Class B common stock is calculated by dividing the net loss of approximately $138,000 and $298,000, less income attributable to Class A common stock of -0-, resulting in a net loss of approximately $138,000 and $298,000 for the three and nine months ended September 30, 2020, respectively, by the weighted average number of Class B common stock outstanding for the periods.

Income Taxes

The Company complies with the accounting and reporting requirements of Financial Accounting Standards Board Accounting Standard Codification, or FASB ASC, 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of September 30, 2020 and December 31, 2019, the Company has a deferred tax asset of approximately $70,000 and $300, respectively, related to start-up costs, which has a full valuation allowance recorded against it.

There were no unrecognized tax benefits as of September 30, 2020 or December 31, 2019. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at September 30, 2020 or December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

The Company’s currently taxable income primarily consists of interest income on the Trust Account, less any franchise taxes. The Company’s formation and operating costs are generally considered start-up costs and are not currently deductible. During the three and nine months ended September 30, 2020, the Company recorded $12,573 of income tax expense. The Company’s effective tax rates for three and nine months ended September 30, 2020 were negative (10%) and (4%), respectively, which differ from the expected income tax rate due to start-up costs (discussed above) which are not currently deductible.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company's financial statements.

DFP HEALTHCARE ACQUISITIONS CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

3. Initial Public Offering.

Public Units

On March 13, 2020, the Company consummated its Initial Public Offering of 23,000,000 Units, including 3,000,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $10.4 million, inclusive of approximately $6.3 million in deferred underwriting commissions. Of the Units sold in the Initial Public Offering, 5,000,000 Units were purchased by certain domestic private pooled investment vehicles managed by Deerfield Management Company, L.P. and its affiliates (the “Deerfield Funds”).

Each Unit consists of one of the Company's shares of Class A common stock, $0.0001 par value, and one-fourth of one redeemable warrant (the “Warrants”). Each whole Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share. The exercise price and number of shares of Class A common stock issuable upon exercise of the Warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation.

4. Related Party Transactions.

Founder Shares

On December 30, 2019, the Sponsor received 4,312,500 shares of Class B common stock (the “Founder Shares”) in exchange for a capital contribution of $25,000, or approximately $0.004 per share. In January 2020, the Sponsor transferred 100,000 Founder Shares to each of Steven Hochberg, the Company's President and Chief Executive Officer, Christopher Wolfe, the Company's Chief Financial Officer and Secretary, and Richard Barasch, the Company's Executive Chairman, and 30,000 Founder Shares to each of Dr. Jennifer Carter, Dr. Mohit Kaushal and Dr. Gregory Sorensen, the Company's independent director nominees, for the same per-share price initially paid by the Sponsor, resulting in the Sponsor holding 3,922,500 Founder Shares. On February 19, 2020, the Company effected a split of its Class B common stock resulting in the Sponsor holding 5,360,000 Founder Shares, resulting in an increase in the total number of Founder Shares from 4,312,500 to 5,750,000. Of the 5,750,000 Founder Shares, up to 750,000 shares were subject to forfeiture by the initial stockholders depending on the exercise of the underwriters' over-allotment option. The underwriters exercised their over-allotment option in full on March 13, 2020; thus, the Founder Shares are no longer subject to forfeiture.

The Founder Shares are identical to the shares of Class A common stock included in the Units being sold in the Initial Public Offering except that the Founder Shares are subject to certain transfer restrictions.

The initial stockholders have agreed not to transfer, assign or sell any of their Founder Shares until the earlier of (A) one year after the completion of the Company's initial Business Combination, or earlier if, subsequent to the Company's initial Business Combination, the closing price of the Company's common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company's initial Business Combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the initial Business Combination that results in all of the Company's stockholders having the right to exchange their common stock for cash, securities or other property.

Private Placement Warrants

Simultaneously with the closing of the Initial Public Offering, the Company sold 3,733,334 Private Placement Warrants to the Sponsor at a price of $1.50 per Private Placement Warrant in a Private Placement, generating proceeds of $5.6 million.

Each Private Placement Warrant entitles the holder to purchase one share of Class A common stock at $11.50 per share. Certain proceeds of the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination, the proceeds of the Private Placement will be part of the liquidating distribution to the Public Stockholders and the Warrants issued to the Sponsor will expire worthless.

DFP HEALTHCARE ACQUISITIONS CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Sponsor Loans

The Sponsor agreed to loan the Company up to an aggregate of $200,000 by the issuance of an unsecured promissory note (the “Note”) to cover expenses related to this Initial Public Offering. The Note was payable without interest upon the completion of the Initial Public Offering. The Company received the $200,000 proceeds under the Note and repaid this Note in full on March 13, 2020.

Administrative Services Agreement

Commencing on the date that the Company's securities were first listed on Nasdaq, the Company has paid and will pay the Sponsor $10,000 per month for office space, secretarial and administrative services provided to members of the Company's management team. Upon completion of the initial Business Combination or the Company's liquidation, the Company will cease paying such monthly fees. The Company incurred $30,000 and $70,000 in expenses in connection with such services during the three and nine months ended September 30, 2020, respectively, as included in general and administrative expenses - related party on the accompanying unaudited condensed statements of operations. As of September 30, 2020 and December 31, 2019, the Company had $10,000 and $0 in connection with such services in accrued expenses to related parties, respectively, as included in the accompanying unaudited condensed balance sheets.

Wolfe Strategic Services Agreement

Commencing on the date that the Company's securities were first listed on Nasdaq, the Company will pay and has paid its Chief Financial Officer, Christopher Wolfe, $7,500 per month for his services prior to the initial Business Combination. The Company incurred $22,500 and $52,500 in expenses in connection with such services during the three and nine months ended September 30, 2020, respectively, included in general and administrative expenses - related party on the accompanying unaudited condensed statement of operations. As of September 30, 2020, and December 31, 2019, the Company had $7,500 and $0 in connection with such services in accrued expenses to related parties, respectively, as included in the accompanying unaudited condensed balance sheets.

Working Capital Loans

In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company's officers and directors may, but are not obligated to, loan the Company funds as may be required for working capital (the “Working Capital Loans”). Up to $1.1 million of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. As of September 30, 2020, except for the foregoing, the terms of such loans, if any, have not been determined, no written agreements exist with respect to such loans and no amounts have been borrowed under such loans to date.

5. Commitments and Contingencies.

Registration Rights

The initial stockholders and holders of the Private Placement Warrants are entitled to registration rights pursuant to a registration rights agreement. The initial stockholders and holders of the Private Placement Warrants will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by the Company. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45-day option to purchase up to 3,000,000 additional Units to cover any over-allotments, at the initial public offering price less the underwriting discounts and commissions. The warrants that were issued in connection with the 3,000,000 over-allotment Units are identical to the public warrants and have no net cash settlement provisions. The underwriters exercised the over-allotment option in full on March 13, 2020.

The underwriters did not receive any underwriting discounts or commission on the Units purchased by the Deerfield Funds. The Company paid an underwriting discount of 2.0% of the per Unit offering price, or $3.6 million, at the closing of the Initial Public Offering, with an additional fee (the “Deferred Underwriting Fees”) of 3.5% of the gross offering proceeds, or $6.3 million, payable upon the Company's completion of an Initial Business Combination. The Deferred Underwriting Fees will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes its initial Business Combination.

DFP HEALTHCARE ACQUISITIONS CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic on its industry and has concluded that, while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

6. Stockholders’ Equity.

Class A Common Stock—The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of December 31, 2019, there were no shares of Class A common stock issued or outstanding. As of September 30, 2020, there were 23,000,000 shares of Class A common stock issued or outstanding, including 21,989,872 shares of Class A common stock subject to possible redemption.

Class B Common Stock—The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of the Company's Class B common stock are entitled to one vote for each share. On December 30, 2019, the Company initially issued 4,312,500 shares of Class B common stock. On February 19, 2020, in connection with the proposed increase of the size of the Initial Public Offering, the Company effected a split of its Class B common stock resulting in the Sponsor holding 5,360,000 Founder Shares and an increase in the total number of Class B common stock outstanding from 4,312,500 to 5,750,000. Of the 5,750,000 shares of Class B common stock outstanding, up to 750,000 shares were subject to forfeiture to the Company to the extent that the underwriters' over-allotment option was not exercised in full or in part, so that the initial stockholders would collectively own 20% of the Company's issued and outstanding common stock after the Initial Public Offering. The underwriters exercised their over-allotment option in full on March 13, 2020; thus, the 750,000 shares of Class B common stock were no longer subject to forfeiture. As of September 30, 2020 and December 31, 2019, there were 5,750,000 shares of Class B common stock issued outstanding.

The Class B common stock will automatically convert into Class A common stock at the time of the Initial Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of shares of Class A common stock issuable upon conversion of all Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by Public Stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans, provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

Preferred Stock—The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. At September 30, 2020 and December 31, 2019, there are no shares of preferred stock issued or outstanding.

Warrants—Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their Public Warrants on a cashless basis under certain circumstances). The Company has agreed that, as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its best efforts to file with the SEC and have declared effective a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrantholders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company's shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

DFP HEALTHCARE ACQUISITIONS CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination and they will be non-redeemable for cash so long as they are held by the initial purchasers of the Private Placement Warrants or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers of the Private Placement Warrants or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the warrants included in the Units being sold in the Initial Public Offering.

The Company may call the Public Warrants for redemption:

in whole and not in part;

at a price of $0.01 per warrant;

upon a minimum of 30 days' prior written notice of redemption; and

if, and only if, the last reported sales price of the Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within the 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

In addition, commencing ninety days after the warrants become exercisable, the Company may redeem the outstanding warrants for shares of Class A common stock:

in whole and not in part;

at a price of $0.10 per warrant upon a minimum of 30 days' prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities—Warrants—Public Stockholders' Warrants” based on the redemption date and the “fair market value” of our Class A common stock (as defined below) except as otherwise described in “Description of Securities—Warrants—Public Stockholders' Warrants”;

if, and only if, the last reported sale price of its Class A common stock equals or exceeds $10.00 per share (as adjusted per stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which it sends the notice of redemption to the warrant holders;

if, and only if, the Private Placement Warrants are also concurrently exchanged at the same price (equal to a number of shares of Class A common stock) as the outstanding Public Warrants, as described above; and

if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given.

The “fair market value” of the Company's Class A common stock shall mean the average last reported sale price of its Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. This redemption feature differs from the typical warrant redemption features used in other blank check offerings.

No fractional shares of Class A common stock will be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of shares of Class A common stock to be issued to the holder.

DFP HEALTHCARE ACQUISITIONS CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Pursuant to the warrant agreement, references above to Class A common stock shall include a security other than Class A common stock into which the Class A common stock has been converted or exchanged for in the event the Company is not the surviving company in its initial Business Combination.

In no event will the Company be required to net cash settle any warrant. If the Company does not complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company's assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

7. Fair Value Measurements.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2020 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.

September 30, 2020

	Quoted Prices in		Significant Other		Significant Other
	Active Markets		Observable Inputs		Unobservable Inputs
Description	(Level 1)		(Level 2)		(Level 3)
Assets held in Trust Account:
U.S. Treasury securities	$	230,173,491	$	-	$	-
Cash and Cash equivalents	$	21,410
	$	230,194,901	$	-	$	-

Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels for the three and nine months ended September 30, 2020.

Level 1 instruments include investments in money market funds and U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.

8. Subsequent Events.

Management has evaluated subsequent events and transactions that occurred after the balance sheet date up through the date the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “our,” “us” or “we” refer to DFP Healthcare Acquisitions Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this Form 10-Q. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings.

Overview

We are a blank check company incorporated on November 1, 2019 as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). We intend to focus our investment effort broadly across the entire healthcare industry, which encompasses services, therapeutics, devices, diagnostics and animal health. We intend to effectuate our initial Business Combination using cash from the proceeds of this offering and the private placement of the private placement warrants, the proceeds of the sale of our shares in connection with our initial Business Combination (pursuant to forward purchase agreements or backstop agreements we may enter into following the consummation of our initial public offering or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing. Our sponsor is DFP Sponsor LLC, a Delaware limited liability company (the “Sponsor”).

Our registration statement for our initial public offering (the “Initial Public Offering”) was declared effective by the SEC on March 10, 2020. On March 13, 2020, we consummated our Initial Public Offering of 23,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), including 3,000,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $10.4 million, inclusive of approximately $6.3 million in deferred underwriting commissions.

Simultaneously with the closing of the Initial Public Offering, we consummated the private placement (“Private Placement”) of 3,733,334 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to our Sponsor, generating proceeds of $5.6 million.

Upon the closing of the Initial Public Offering and the Private Placement, $230.00 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (the “Trust Account”) and was invested in permitted United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, which we refer to as the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act that invest only in direct U.S. government treasury obligations.

Our management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.

We will only have 24 months from the closing of the Initial Public Offering, or March 13, 2022, to complete our initial Business Combination (the “Combination Period”). If we do not complete a Business Combination within this period of time, it will (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares for a per share pro rata portion of the Trust Account, including interest and not previously released to us to fund our working capital requirements (subject to an annual limit of $500,000) (less taxes payable and up to $100,000 of such net interest to pay dissolution expenses) and (iii) as promptly as possible following such redemption, liquidate and dissolve the balance of our net assets to our remaining stockholders, as part of our plan of dissolution and liquidation.

The issuance of additional shares in connection with a Business Combination to the owners of the target or other investors:

may significantly dilute the equity interest of investors in this offering, which dilution would increase if the anti-dilution provisions in the Class B common stock resulted in the issuance of Class A common stock on a greater than one-to-one basis upon conversion of the Class B common stock;

may subordinate the rights of holders of Class A common stock if shares of preferred stock are issued with rights senior to those afforded our Class A common stock;

could cause a change in control if a substantial number of shares of our Class A common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;

may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; and

may adversely affect prevailing market prices for our units, Class A common stock and/or warrants.

Similarly, if we issue debt securities or otherwise incur significant debt to bank or other lenders or the owners of a target, it could result in:

default and foreclosure on our assets if our operating revenues after an initial Business Combination are insufficient to repay our debt obligations;

acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;

our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand;

our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding;

our inability to pay dividends on our Class A common stock;

using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A common stock if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;

limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;

increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and

limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.

As indicated in the accompanying unaudited condensed financial statements, at September 30, 2020, we had approximately $1.0 million in our operating bank account. We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete our initial Business Combination will be successful.

Results of Operations

Our entire activity from inception through September 30, 2020 related to our formation, the preparation for the Initial Public Offering, and, since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. We have neither engaged in any operations nor generated any revenues to date. We will not generate any operating revenues until after completion of our initial Business Combination. We will generate non-operating income in the form of interest income on our investments held in the Trust Account. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the three months ended September 30, 2020, we had a net loss of approximately $138,000, which consisted of approximately $73,000 in net gain from investments held in the Trust Account, offset by approximately $96,000 in general and administrative expenses, $52,000 in administrative expenses – related party, approximately $50,000 in franchise tax expense, and approximately $13,000 in income tax expense.

For the nine months ended September 30, 2020, we had a net loss of approximately $298,000, which consisted of approximately $195,000 in net gain from investments held in the Trust Account, offset by approximately $209,000 in general and administrative expenses, $122,000 in administrative expenses – related party, approximately $149,000 in franchise tax expense, and approximately $13,000 in income tax expense.

Liquidity and Capital Resources

As of September 30, 2020, we had approximately $1.0 million in our operating bank account, working capital of approximately $1.0 million, and approximately $195,000 of interest income available in the Trust Account for our tax obligations, if any.

Our liquidity needs to date have been satisfied through a $25,000 contribution from our Sponsor in exchange for the issuance of our founder shares to our Sponsor, the promissory note of $200,000 from our Sponsor, and the proceeds from the consummation of the Private Placement not held in the Trust Account. On March 13, 2020, we repaid the promissory note in full to our Sponsor. In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor, or certain of our officers and directors may, but are not obligated to, provide us Working Capital Loans. As of September 30, 2020, there were no Working Capital Loans outstanding.

Management continues to evaluate the impact of the COVID-19 pandemic on our industry and has concluded that, while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Based on the foregoing, our management believes that we will have sufficient working capital and borrowing capacity from our Sponsor or an affiliate of our Sponsor, or certain of our officers and directors to meet our needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, we will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Contractual Obligations

We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities, other than an agreement to pay our Sponsor a monthly fee of $10,000 for office space, secretarial and administrative services and an agreement to pay our Chief Financial Officer, Christopher Wolfe, $7,500 per month for his services prior to the initial Business Combination.

Registration Rights

The initial stockholders and holders of the Private Placement Warrants are entitled to registration rights pursuant to a registration rights agreement. The initial stockholders and holders of the Private Placement Warrants will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by the Company. We will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

We granted the underwriters a 45-day option to purchase up to 3,000,000 additional Units to cover any over-allotments, at the initial public offering price of $10.00 per Unit, less the underwriting discounts and commissions. The warrants that were be issued in connection with the 3,000,000 over-allotment Units are identical to the public warrants and have no net cash settlement provisions. The underwriters exercised the over-allotment option in full on March 13, 2020.

The underwriters did not receive any underwriting discounts or commission on the 5,000,000 Units purchased in the Initial Public Offering by certain domestic private pooled investment vehicles managed by Deerfield Management Company, L.P. We paid an underwriting discount of 2.0% of the per Unit offering price, or $3.6 million, at the closing of the Initial Public Offering, with an additional fee (the “Deferred Underwriting Fees”) of 3.5% of the gross offering proceeds, or $6.3 million, payable upon the Company's completion of an Initial Business Combination. The Deferred Underwriting Fees will become payable to the underwriters from the amounts held in the Trust Account solely in the event we complete our initial Business Combination.

Critical Accounting Policies

Use of Estimates

This management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with GAAP. The preparation of our financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We have identified the following as its critical accounting policies:

Investments Held in the Trust Account

Our portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on marketable securities, dividends and interest held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

Class A Common Stock subject to possible redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2020 and December 31, 2019, 21,989,872 and 0 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets, respectively.

Net Loss Per Share of Common Stock

Our unaudited condensed statements of operations include a presentation of loss per share for common stock subject to redemption in a manner similar to the two-class method of income (loss) per share. Net loss per common stock, basic and diluted for Class A common stock are calculated by dividing the interest income earned on marketable securities held in the Trust Account of approximately $73,000 and approximately $195,000, less approximately $63,000 and approximately $162,000 of maximum allowance for tax obligations, minus approximately $11,000 and approximately $33,000 for working capital, resulting in no income for Class A common stock for the three and nine months ended September 30, 2020, by the weighted average number of Class A common stock outstanding for the periods. Net loss per common stock, basic and diluted for Class B common stock is calculated by dividing the net loss of approximately $138,000 and approximately $298,000, less income attributable to Class A common stock of -0-, resulting in a net loss of approximately $138,000 and approximately $298,000 for the three and nine months ended September 30, 2020, by the weighted average number of Class B common stock outstanding for the periods.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on our financial statements.

Off-Balance Sheet Arrangements

As of September 30, 2020, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

Inflation

We do not believe that inflation had a material impact on our business, revenues or operating results during the periods presented.

JOBS Act

On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” under the JOBS Act and are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We elected to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

As an “emerging growth company”, we are not required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our initial public offering or until we are no longer an “emerging growth company,” whichever is earlier.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

Item 4.

Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial and Accounting Officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2020, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our President and Chief Executive Officer and Chief Financial Officer and Secretary have concluded that during the period covered by this report, our disclosure controls and procedures were effective.

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial and Accounting Officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended September 30, 2020 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1.

Legal Proceedings.

None.

Item 1A.

Risk Factors.

Factors that could cause our actual results to differ materially from those in this Quarterly Report on Form 10-Q are any of the risks described in our final prospectus relating to the Initial Public Offering dated March 10, 2020 filed with the SEC on March 12, 2020 (the “Prospectus”), and our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2020 filed with the SEC on May 8, 2020. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

As of the date of this Quarterly Report on Form 10-Q, we note the following additional risk factor:

The securities in which we invest the proceeds held in the trust account could bear a negative rate of interest, which could reduce the interest income available for payment of taxes or reduce the value of the assets held in trust such that the per share redemption amount received by stockholders may be less than $10.00 per share.

The net proceeds of the Initial Public Offering and certain proceeds from the sale of the private placement warrants, in the amount of $230,000,000, is being held in an interest-bearing trust account. The proceeds held in the trust account may only be invested in direct U.S. Treasury obligations having a maturity of 185 days or less, or in certain money market funds which invest only in direct U.S. Treasury obligations. While short-term U.S. Treasury obligations currently yield a positive rate of interest, they have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates below zero in recent years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the future adopt similar policies in the United States. In the event of very low or negative yields, the amount of interest income (which we may withdraw to pay income taxes, if any) would be reduced. In the event that we are unable to complete our initial business combination, our public stockholders are entitled to receive their pro-rata share of the proceeds held in the trust account, plus any interest income. If the balance of the trust account is reduced below $230,000,000 as a result of negative interest rates, the amount of funds in the trust account available for distribution to our public stockholders may be reduced below $10.00 per share.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities.

On December 30, 2019, our Sponsor purchased an aggregate of 4,312,500 of our Class B common stock (the “founder shares”), in exchange for a capital contribution of $25,000 at an average purchase price of approximately $0.004 per share. Such securities were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. In January 2020, our Sponsor transferred 100,000 founder shares to each of Steven Hochberg, our Chief Executive Officer and President, Christopher Wolfe, our Chief Financial Officer and Secretary, and Richard Barasch our Executive Chairman, and 30,000 founder shares to each of Dr. Jennifer Carter, Dr. Mohit Kaushal and Dr. Gregory Sorensen, our independent director nominees, for the same per-share price initially paid by our Sponsor, resulting in our Sponsor holding 3,922,500 founder shares. On February 19, 2020, we effected a 1:11/3 stock split of our Class B common stock resulting in our Sponsor holding 5,360,000 founder shares. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 23,000,000 units if the underwriters' over-allotment option was exercised in full and therefore that such founder shares would represent 20% of the outstanding shares after this offering. Up to 750,000 of these shares would be forfeited depending on the extent to which the underwriters' over-allotment was exercised.

Our Sponsor is an accredited investor for purposes of Rule 501 of Regulation D. Each of the equity holders in our Sponsor is an accredited investor under Rule 501 of Regulation D. The sole business of our Sponsor is to act as the company's sponsor in connection with this offering. The limited liability company agreement of our Sponsor provides that its membership interests may only be transferred to our officers or directors or other persons affiliated with our Sponsor, or in connection with estate planning transfers.

Simultaneously with the closing of our Initial Public Offering, pursuant to a Private Placement Warrants Purchase Agreement, the Company completed the private sale of an aggregate of 3,733,334 warrants (the “Private Placement Warrants”) to our Sponsor at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $5,600,000. The Private Placement Warrants are identical to the Warrants sold in the Initial Public Offering, except that the Private Placement Warrants, so long as they are held by our Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until 30 days after the completion of the Company’s initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

No underwriting discounts or commissions were paid with respect to such sales.

Item 3.

Defaults Upon Senior Securities.

None.

Item 4.

Mine Safety Disclosures.

Not applicable.

Item 5.

Other Information.

None.

Item 6.

Exhibits.

Exhibit Number		Description
31.1*		Certification of President and Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*		Certification of Chief Financial Officer and Secretary Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**		Certification of President and Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**		Certification of Chief Financial Officer and Secretary Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

Filed herewith.

These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 13th day of November, 2020.

	DFP HEALTHCARE ACQUISITIONS CORP.

	By:	/s/ Christopher Wolfe
		Name:	Christopher Wolfe
		Title:	Chief Financial Officer

Dated: November 13, 2020

EX-31.1 2 tm2029632d1_ex31-1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Steven Hochberg, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 of DFP Healthcare Acquisitions Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

[Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942];

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: November 13, 2020	By:	/s/ Steven Hochberg
		Steven Hochberg
		President and Chief Executive Officer (Principal Executive Officer)

EX-31.2 3 tm2029632d1_ex31-2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Christopher Wolfe, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 of DFP Healthcare Acquisitions Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

[Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942];

5.	The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: November 13, 2020	By:	/s/ Christopher Wolfe
		Christopher Wolfe
		Chief Financial Officer and Secretary (Principal Financial and Accounting Officer)

EX-32.1 4 tm2029632d1_ex32-1.htm EXHIBIT 32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of DFP Healthcare Acquisitions Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Steven Hochberg, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 13, 2020

	/s/ Steven Hochberg
	Name:	Steven Hochberg
	Title:	President and Chief Executive Officer (Principal Executive Officer)

EX-32.2 5 tm2029632d1_ex32-2.htm EXHIBIT 32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of DFP Healthcare Acquisitions Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christopher Wolfe, Chief Financial Officer and Secretary of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 13, 2020

	/s/ Christopher Wolfe
	Name:	Christopher Wolfe
	Title:	Chief Financial Officer and Secretary (Principal Financial and Accounting Officer)

EX-101.INS 6 dfphu-20200930.xml XBRL INSTANCE DOCUMENT 0001799191 us-gaap:RetainedEarningsMember 2020-09-30 0001799191 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001799191 us-gaap:RetainedEarningsMember 2020-06-30 0001799191 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001799191 2020-06-30 0001799191 us-gaap:RetainedEarningsMember 2020-03-31 0001799191 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001799191 2020-03-31 0001799191 us-gaap:RetainedEarningsMember 2019-12-31 0001799191 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001799191 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-09-30 0001799191 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-09-30 0001799191 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-06-30 0001799191 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-06-30 0001799191 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-03-31 0001799191 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-03-31 0001799191 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2019-12-31 0001799191 dfphu:WolfeStrategicServicesAgreementMember 2020-07-01 2020-09-30 0001799191 dfphu:AdministrativeServicesAgreementMember 2020-07-01 2020-09-30 0001799191 srt:MaximumMember dfphu:SponsorLoansMember 2020-01-01 2020-09-30 0001799191 dfphu:SponsorLoansMember 2020-03-13 2020-03-13 0001799191 dfphu:WorkingCapitalLoansMember 2020-01-01 2020-09-30 0001799191 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001799191 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001799191 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001799191 us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-09-30 0001799191 us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0001799191 us-gaap:CommonClassBMember 2020-07-01 2020-09-30 0001799191 us-gaap:CommonClassBMember 2019-12-31 0001799191 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2020-09-30 0001799191 us-gaap:CommonClassAMember 2020-03-13 0001799191 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member 2020-09-30 0001799191 us-gaap:CashEquivalentsMember us-gaap:FairValueInputsLevel1Member 2020-09-30 0001799191 us-gaap:FairValueInputsLevel1Member 2020-09-30 0001799191 us-gaap:WarrantMember 2020-01-01 2020-09-30 0001799191 us-gaap:PrivatePlacementMember 2020-09-30 0001799191 dfphu:WorkingCapitalLoansMember 2020-09-30 0001799191 us-gaap:OverAllotmentOptionMember 2020-03-13 2020-03-13 0001799191 dfphu:DeerfieldManagementCompanyL.pMember 2020-03-13 2020-03-13 0001799191 us-gaap:CommonClassBMember 2020-02-19 0001799191 dfphu:PrivatePlacementWarrantsMember 2020-01-01 2020-09-30 0001799191 dfphu:StevenHochbergCompanySPresidentAndChiefExecutiveOfficerMember dfphu:SponsorMember us-gaap:CommonClassBMember 2020-01-01 2020-01-31 0001799191 dfphu:RichardBaraschCompanySExecutiveChairmanMember dfphu:SponsorMember us-gaap:CommonClassBMember 2020-01-01 2020-01-31 0001799191 dfphu:Dr.MohitKaushalMember dfphu:SponsorMember us-gaap:CommonClassBMember 2020-01-01 2020-01-31 0001799191 dfphu:Dr.JenniferCarterMember dfphu:SponsorMember us-gaap:CommonClassBMember 2020-01-01 2020-01-31 0001799191 dfphu:Dr.GregorySorensenMember dfphu:SponsorMember us-gaap:CommonClassBMember 2020-01-01 2020-01-31 0001799191 dfphu:ChristopherWolfeCompanySChiefFinancialOfficerAndSecretaryMember dfphu:SponsorMember us-gaap:CommonClassBMember 2020-01-01 2020-01-31 0001799191 dfphu:WolfeStrategicServicesAgreementMember 2020-01-01 2020-09-30 0001799191 dfphu:AdministrativeServicesAgreementMember 2020-01-01 2020-09-30 0001799191 us-gaap:OverAllotmentOptionMember 2020-01-01 2020-09-30 0001799191 us-gaap:CommonClassBMember 2020-02-19 2020-02-19 0001799191 us-gaap:CommonClassAMember 2020-03-13 2020-03-13 0001799191 dfphu:SponsorMember us-gaap:CommonClassBMember 2020-02-19 2020-02-19 0001799191 dfphu:SponsorMember us-gaap:CommonClassBMember 2020-01-01 2020-01-31 0001799191 us-gaap:CommonClassAMember 2020-07-01 2020-09-30 0001799191 srt:MaximumMember dfphu:WorkingCapitalLoansMember 2020-09-30 0001799191 2019-12-31 0001799191 us-gaap:IPOMember 2020-03-13 2020-03-13 0001799191 us-gaap:IPOMember 2020-03-13 0001799191 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001799191 2020-07-01 2020-09-30 0001799191 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001799191 2020-04-01 2020-06-30 0001799191 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001799191 2020-01-01 2020-03-31 0001799191 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001799191 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001799191 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001799191 us-gaap:CommonClassAMember 2019-12-31 0001799191 us-gaap:CommonClassBMember 2020-09-30 0001799191 us-gaap:CommonClassAMember 2020-09-30 0001799191 dfphu:RedemptionOfWarrantsCommencingNinetyDaysAfterWarrantsBecomeExercisableMember 2020-09-30 0001799191 dfphu:RedemptionOfWarrantsCommencingNinetyDaysAfterWarrantsBecomeExercisableMember us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0001799191 us-gaap:PrivatePlacementMember 2020-01-01 2020-09-30 0001799191 dfphu:RedemptionOfWarrantsCommencingNinetyDaysAfterWarrantsBecomeExercisableMember 2020-01-01 2020-09-30 0001799191 dfphu:SponsorMember us-gaap:CommonClassBMember 2019-12-30 2019-12-30 0001799191 us-gaap:CommonClassBMember 2020-01-01 2020-09-30 0001799191 dfphu:WolfeStrategicServicesAgreementMember 2020-09-30 0001799191 dfphu:AdministrativeServicesAgreementMember 2020-09-30 0001799191 2020-09-30 0001799191 dfphu:WolfeStrategicServicesAgreementMember 2019-12-31 0001799191 dfphu:AdministrativeServicesAgreementMember 2019-12-31 0001799191 us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0001799191 dfphu:WarrantExercisableForClassOrdinaryShareMember 2020-01-01 2020-09-30 0001799191 dfphu:ClassOrdinaryShareAndOneFourthOfOneRedeemableWarrantMember 2020-01-01 2020-09-30 0001799191 us-gaap:CommonClassBMember 2020-11-13 0001799191 us-gaap:CommonClassAMember 2020-11-13 0001799191 2020-01-01 2020-09-30 iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares false --12-31 Q3 2020 2020-09-30 10-Q 0001799191 23000000 5750000 Yes true false Non-accelerated Filer Yes DFP HEALTHCARE ACQUISITIONS CORP. true true Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share Class A common stock, par value $0.0001 per share NASDAQ NASDAQ NASDAQ DFPHU DFPHW DFPH 0 0 17500 10000 7500 0.20 0.004 P2D P2D 0 -265710 P30D P30D 1.50 18.00 10.00 P30D P20D P90D 0.01 0.10 23000000 23000000 1 0 21989872 21989872 220164430 <div> <div> Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September  30, 2020 and December 31, 2019, 21,989,872 and -0- shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets, respectively. <div /></div> </div> 22015212 -11574 -13766 220152120 220149918 2202 -115740 -115738 -2 -137660 -137659 -1 10 25000 6300000000 6300000 6300000 6300000 6300000 0.035 149750 50000 800 150100 17500 149300 0.20 1100000 162000 500000 500000 P15D 63000 100000 5000001 200000 3922500 5360000 5360000 1 750000 750000 0.25 1.00 <div> <div> Offering Costs The Company complies with the requirements of the ASC 340‑10‑S99‑1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering, and were charged to stockholders’ equity upon the completion of the Initial Public Offering. <div /></div> </div> P45D 230000000 -0.04 -0.10 230000000 <div> <div> 3. Initial Public Offering. Public Units On March 13, 2020, the Company consummated its Initial Public Offering of 23,000,000 Units, including 3,000,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $10.4 million, inclusive of approximately $6.3 million in deferred underwriting commissions. Of the Units sold in the Initial Public Offering, 5,000,000 Units were purchased by certain domestic private pooled investment vehicles managed by Deerfield Management Company, L.P. and its affiliates (the “Deerfield Funds”). Each Unit consists of one of the Company’s shares of Class A common stock, $0.0001 par value, and one-fourth of one redeemable warrant (the “Warrants”). Each whole Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share. The exercise price and number of shares of Class A common stock issuable upon exercise of the Warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. <div /></div> </div> 1.00 10000 7500 100000 30000 30000 30000 100000 100000 0 21989872 P10D P150D P30D P30D P1Y P24M 5750000 5750000 5750000 12.00 P30D P20D 3600000 0.020 5000000 23000000 23000000 3000000 3000000 3000000 P30D P12M 1.50 1.50 1000000 33000 11000 0

1329

26500

28000

24425

5300118

10425486

5600000

9483334

50000

231395659

25000

1200758

230194901

21410

230173491

230194901

25000

998571

1000000

25000

998571

973571

11.50

3733334

<div> <div> 5. Commitments and Contingencies. Registration Rights The initial stockholders and holders of the Private Placement Warrants are entitled to registration rights pursuant to a registration rights agreement. The initial stockholders and holders of the Private Placement Warrants will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by the Company. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option to purchase up to 3,000,000 additional Units to cover any over-allotments, at the initial public offering price less the underwriting discounts and commissions. The warrants that were issued in connection with the 3,000,000 over-allotment Units are identical to the public warrants and have no net cash settlement provisions. The underwriters exercised the over-allotment option in full on March 13, 2020. The underwriters did not receive any underwriting discounts or commission on the Units purchased by the Deerfield Funds. The Company paid an underwriting discount of 2.0% of the per Unit offering price, or $3.6 million, at the closing of the Initial Public Offering, with an additional fee (the “Deferred Underwriting Fees”) of 3.5% of the gross offering proceeds, or $6.3 million, payable upon the Company's completion of an Initial Business Combination. The Deferred Underwriting Fees will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes its initial Business Combination. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on its industry and has concluded that, while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. <div /></div> </div>

0.0001

100000000

10000000

100000000

10000000

5750000

1010128

5750000

1010128

5750000

575

101

575

<div> <div> Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. <div /></div> </div>

25000

300

70000

-0.05

-0.02

<div> <div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Quoted Prices in </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant Other </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant Other </td> </tr> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Active Markets </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Observable Inputs </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unobservable Inputs </td> </tr> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Description </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 1) </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 2) </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Assets held in Trust Account: </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. Treasury securities </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 230,173,491 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Cash and Cash equivalents  </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 21,410 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 230,194,901 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> </table></div>   <div /></div> </div>

<div> <div> 7. Fair Value Measurements. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2020 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. September 30, 2020 <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Quoted Prices in </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant Other </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant Other </td> </tr> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Active Markets </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Observable Inputs </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unobservable Inputs </td> </tr> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Description </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 1) </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 2) </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Assets held in Trust Account: </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. Treasury securities </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 230,173,491 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Cash and Cash equivalents  </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 21,410 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:54.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 230,194,901 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> </table></div>   Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels for the three and nine months ended September 30, 2020. Level 1 instruments include investments in money market funds and U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. <div /></div> </div>

<div> <div> Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset, or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</td></tr></table></div> In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of September 30, 2020 and December 31, 2019, the carrying values of cash, accounts payable, accrued expenses, and tax obligations approximate their fair values due to the short-term nature of the instruments. The Company’s portfolio of marketable securities held in the Trust Account is comprised mainly of investments in U.S. Treasury securities with an original maturity of 185 days or less. The fair value for trading securities is determined using quoted market prices in active markets. <div /></div> </div>

208562

95980

-285911

-125087

12573

1329

26500

202187

194901

195000

73393

74000

27300

6496929

50000

231395659

27300

196929

231474514

-230000000

-500943

-45089

-298484

-298000

-115735

-137660

-138000

-137660

-298000

-138000

<div> <div> Recent Accounting Pronouncements Management does not believe that any  recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements. <div /></div> </div>

-480812

-198480

<div> <div> 1. Organization, Business Operations and Basis of Presentation. Incorporation DFP Healthcare Acquisitions Corp. (the “Company”) was incorporated as a Delaware corporation on November 1, 2019. Sponsor The Company’s sponsor is DFP Sponsor LLC, a Delaware limited liability company (the “Sponsor”). Fiscal Year End The Company has selected December 31 as its fiscal year end. Business Purpose The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more operating businesses that it has not yet selected (“Business Combination”). The Company has neither engaged in any operations nor generated revenue to date. As of September 30, 2020, the Company had not commenced any operations. All activity for the period from November 1, 2019 (inception) through September 30, 2020 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and since the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering, although substantially all of the net proceeds of the Initial Public Offering are intended to be generally applied toward completing a Business Combination. Furthermore, there is no assurance that the Company will be able to successfully complete a Business Combination. Financing The registration statement for the Company’s Initial Public Offering was declared effective by the Securities and Exchange Commission (the “SEC”) on March 10, 2020. On March 13, 2020, the Company consummated its Initial Public Offering of 23,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), including 3,000,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $10.4 million, inclusive of approximately $6.3 million in deferred underwriting commissions (Note 3). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 3,733,334 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor, generating proceeds of $5.6 million (Note 4). Trust Account Upon the closing of the Initial Public Offering and the Private Placement, $230.00 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a  trust account (the “Trust Account”) and invested in permitted United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, which the Company refers to as the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a‑7 promulgated under the Investment Company Act that invest only in direct U.S. government treasury obligations. The Company’s second amended and restated certificate of incorporation provides that, other than the withdrawal of interest earned on the funds that may be released to the Company to pay taxes, none of the funds held in Trust Account will be released until the earlier of: (i) the completion of the Business Combination; (ii) the redemption of the Public Shares to its holders (the “Public Stockholders”) properly tendered in connection with a stockholder vote to amend the Company’s second amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares or with respect to any other material provision relating to stockholders’ rights or pre-initial Business Combination activity, or (iii) the redemption of 100% of the Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering. The Company, after signing a definitive agreement for a Business Combination, will either (i) seek stockholder approval of the Business Combination at a meeting called for such purpose in connection with which stockholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to fund its working capital requirements (subject to an annual limit of $500,000) and/or to pay its taxes, or (ii) provide the Public Stockholders with the opportunity to sell their shares to the Company by means of a tender offer for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to commencement of the tender offer, including interest earned on the funds held in the Trust Account and not previously released to the Company to fund its working capital requirements (subject to an annual limit of $500,000) and/or to pay taxes. The decision as to whether the Company will seek stockholder approval of the Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the outstanding shares of common stock voted are voted in favor of the Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. If the Company holds a stockholder vote in connection with a Business Combination, a Public Stockholder will have the right to redeem its shares for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to fund its working capital requirements (subject to an annual limit of $500,000) and/or to pay its taxes. As a result, such common stock is recorded at redemption amount and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with FASB, ASC 480, “Distinguishing Liabilities from Equity.” The amount in the Trust Account is initially anticipated to be $10.00 per public share ($230.0 million held in the Trust Account divided by 23,000,000 public shares). The Company will have 24 months from the closing of the Initial Public Offering, or until March 13, 2022, to complete its initial Business Combination (the “ Combination Period”). If the Company does not complete a Business Combination within this period of time, it will (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares for a per share pro rata portion of the Trust Account, including interest and not previously released to the Company to fund its working capital requirements (subject to an annual limit of $500,000) (less taxes payable and up to $100,000 of such net interest to pay dissolution expenses) and (iii) as promptly as possible following such redemption, liquidate and dissolve the balance of the Company’s net assets to its remaining stockholders, as part of its plan of dissolution and liquidation. The Sponsor and the Company’s officers and directors (the “initial stockholders”) have entered into a letter agreement with the Company, pursuant to which they have waived their rights to participate in any redemption with respect to their Founder Shares (as defined below); however, if the initial stockholders acquire shares of common stock in or after the Initial Public Offering, they will be entitled to a pro rata share of the Trust Account upon the Company’s redemption of common stock or liquidation in the event the Company does not complete a Business Combination within the required time period. In the event of such a liquidating distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial price per Unit in the Initial Public Offering. Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected through December 31, 2020 or any future period. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the final prospectus and the Form 8‑K filed by the Company with the SEC on March 12, 2020 and March 19, 2020, respectively. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accountant standards used. Liquidity As of September 30, 2020, the Company had approximately $1.0 million in its operating bank account, working capital of approximately $1.0 million, and approximately $195,000 of interest income available in the Trust Account for working capital requirements (subject to an annual limit of $500,000) and/or to pay for the Company’s tax obligations, if any. The Company’s liquidity needs to date have been satisfied through a $25,000 contribution from the Sponsor in exchange for the issuance of the Founder Shares to the Sponsor, the Note (defined below) of $200,000 from the Sponsor, and the proceeds from the consummation of the Private Placement not held in the Trust Account. On March 13, 2020, the Company repaid the Note in full to the Sponsor. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company with Working Capital Loans (see Note 4). As of September 30, 2020, there were no Working Capital Loans outstanding. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. <div /></div> </div>

4125486

10400000

0.0001

1000000

202187

230000000

5600000

230000000

200000

-298484

200000

70000

52500

30000

22500

<div> <div> 4. Related Party Transactions. Founder Shares On December 30, 2019, the Sponsor received 4,312,500 shares of Class B common stock (the “Founder Shares”) in exchange for a capital contribution of $25,000, or approximately $0.004 per share. In January 2020, the Sponsor transferred 100,000 Founder Shares to each of Steven Hochberg, the Company’s President and Chief Executive Officer, Christopher Wolfe, the Company’s Chief Financial Officer and Secretary, and Richard Barasch, the Company’s Executive Chairman, and 30,000 Founder Shares to each of Dr. Jennifer Carter, Dr. Mohit Kaushal and Dr. Gregory Sorensen, the Company’s independent director nominees, for the same per-share price initially paid by the Sponsor, resulting in the Sponsor holding 3,922,500 Founder Shares. On February 19, 2020, the Company effected a split of its Class B common stock resulting in the Sponsor holding 5,360,000 Founder Shares, resulting in an increase in the total number of Founder Shares from 4,312,500 to 5,750,000. Of the 5,750,000 Founder Shares, up to 750,000 shares were subject to forfeiture by the initial stockholders depending on the exercise of the underwriters’ over-allotment option. The underwriters exercised their over-allotment option in full on March 13, 2020; thus, the Founder Shares are no longer subject to forfeiture. The Founder Shares are identical to the shares of Class A common stock included in the Units being sold in the Initial Public Offering except that the Founder Shares are subject to certain transfer restrictions. The initial stockholders have agreed not to transfer, assign or sell any of their Founder Shares until the earlier of (A) one year after the completion of the Company’s initial Business Combination, or earlier if, subsequent to the Company’s initial Business Combination, the closing price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30‑trading day period commencing at least 150 days after the Company’s initial Business Combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the initial Business Combination that results in all of the Company’s stockholders having the right to exchange their common stock for cash, securities or other property. Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company sold 3,733,334 Private Placement Warrants to the Sponsor at a price of $1.50 per Private Placement Warrant in a Private Placement, generating proceeds of $5.6 million. Each Private Placement Warrant entitles the holder to purchase one share of Class A common stock at $11.50 per share. Certain proceeds of the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination, the proceeds of the Private Placement will be part of the liquidating distribution to the Public Stockholders and the Warrants issued to the Sponsor will expire worthless. Sponsor Loans The Sponsor agreed to loan the Company up to an aggregate of $200,000 by the issuance of an unsecured promissory note (the “Note”) to cover expenses related to this Initial Public Offering. The Note was payable without interest upon the completion of the Initial Public Offering. The Company received the $200,000 proceeds under the Note and repaid this Note in full on March 13, 2020. Administrative Services Agreement Commencing on the date that the Company’s securities were first listed on Nasdaq, the Company has paid and will pay the Sponsor $10,000 per month for office space, secretarial and administrative services provided to members of the Company’s management team. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying such monthly fees. The Company incurred $30,000 and $70,000 in expenses in connection with such services during the three and nine months ended September 30, 2020, respectively, as included in general and administrative expenses - related party on the accompanying unaudited condensed statements of operations. As of September 30, 2020 and December 31, 2019, the Company had $10,000 and $0 in connection with such services in accrued expenses to related parties, respectively, as included in the accompanying unaudited condensed balance sheets. Wolfe Strategic Services Agreement Commencing on the date that the Company’s securities were first listed on Nasdaq, the Company will pay and has paid its Chief Financial Officer, Christopher Wolfe, $7,500 per month for his services prior to the initial Business Combination. The Company incurred $22,500 and $52,500 in expenses in connection with such services during the three and nine months ended September 30, 2020, respectively, included in general and administrative expenses - related party on the accompanying unaudited condensed statement of operations. As of September 30, 2020, and December 31, 2019, the Company had $7,500 and $0 in connection with such services in accrued expenses to related parties, respectively, as included in the accompanying unaudited condensed balance sheets. Working Capital Loans In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required for working capital (the “Working Capital Loans”). Up to $1.1 million of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. As of September 30, 2020, except for the foregoing, the terms of such loans, if any, have not been determined, no written agreements exist with respect to such loans and no amounts have been borrowed under such loans to date. <div /></div> </div>

122500

52500

200000

-2300

-300784

10.00

5750000

984788

5750000

996362

5750000

1010128

5750000

21989872

<div> <div> 2. Significant Accounting Policies. Use of Estimates The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company's management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future conforming events. Accordingly, the actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2020 and December 31, 2019. Investments  Held in Trust Account The Company’s portfolio of marketable securities is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the unaudited condensed balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain from investments held in the Trust Account in the accompanying unaudited condensed statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset, or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</td></tr></table></div> In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of September 30, 2020 and December 31, 2019, the carrying values of cash, accounts payable, accrued expenses, and tax obligations approximate their fair values due to the short-term nature of the instruments. The Company’s portfolio of marketable securities held in the Trust Account is comprised mainly of investments in U.S. Treasury securities with an original maturity of 185 days or less. The fair value for trading securities is determined using quoted market prices in active markets. Offering Costs The Company complies with the requirements of the ASC 340‑10‑S99‑1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering, and were charged to stockholders’ equity upon the completion of the Initial Public Offering. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September  30, 2020 and December 31, 2019, 21,989,872 and -0- shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets, respectively. Net Loss Per Share of Common Stock Net loss per share is computed by dividing net loss by the weighted-average number of common stock outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 9,483,334 of the Company’s Class A common stock in the calculation of diluted income per share, since their inclusion would be anti-dilutive under the treasury stock method. The Company’s unaudited condensed statements of operations include a presentation of loss per share for common stock subject to redemption in a manner similar to the two-class method of income (loss) per share. Net loss per common stock, basic and diluted for Class A common stock are calculated by dividing the interest income earned on the investments held in the Trust Account of approximately  $74,000 and    $195,000, less approximately $63,000 and $162,000 of maximum allowance for tax obligations, minus approximately $11,000 and  $33,000 for working capital allowance, resulting in no income for Class A common stock for the three and nine months ended September 30, 2020, respectively, by the weighted average number of Class A common stock outstanding for the periods. Net loss per common stock, basic and diluted for Class B common stock is calculated by dividing the net loss of approximately $138,000 and  $298,000, less income attributable to Class A common stock of -0-, resulting in a net loss of approximately $138,000 and $298,000 for the three and nine months ended September 30, 2020, respectively, by the weighted average number of Class B common stock outstanding for the periods. Income Taxes The Company complies with the accounting and reporting requirements of Financial Accounting Standards Board Accounting Standard Codification, or FASB ASC, 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of September 30, 2020 and December 31, 2019, the Company has a deferred tax asset of approximately $70,000 and $300, respectively, related to start-up costs, which has a full valuation allowance recorded against it. There were no unrecognized tax benefits as of September 30, 2020 or December 31, 2019. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at September 30, 2020 or December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;text-decoration:none;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> The Company’s currently taxable income primarily consists of interest income on the Trust Account,less any franchise taxes. The Company’s formation and operating costs are generally considered start-up costs and are not currently deductible. During the three and nine months ended September 30, 2020, the Company recorded $12,573 of income tax expense. The Company’s effective tax rates for three and nine months ended September 30, 2020 were negative (10%) and (4%), respectively, which differ from the expected income tax rate due to start-up costs (discussed above) which are not currently deductible. Recent Accounting Pronouncements Management does not believe that any  recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements. <div /></div> </div>

22700

24425

-2300

575

5000005

5046721

-47389

575

5000010

5162459

-163124

100

575

5000010

5300118

-300784

101

575

<div> <div> 6. Stockholders’ Equity. Class A Common Stock—The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of December 31, 2019, there were no shares of Class A common stock issued or outstanding.  As of September 30, 2020, there were 23,000,000 shares of Class A common stock issued or outstanding, including 21,989,872 shares of Class A common stock subject to possible redemption. Class B Common Stock—The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of the Company’s Class B common stock are entitled to one vote for each share. On December 30, 2019, the Company initially issued 4,312,500 shares of Class B common stock. On February 19, 2020, in connection with the proposed increase of the size of the Initial Public Offering, the Company effected a split of its Class B common stock resulting in the Sponsor holding 5,360,000 Founder Shares and an increase in the total number of Class B common stock outstanding from 4,312,500 to 5,750,000. Of the 5,750,000 shares of Class B common stock outstanding, up to 750,000 shares were subject to forfeiture to the Company to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the initial stockholders would collectively own 20% of the Company’s issued and outstanding common stock after the Initial Public Offering. The underwriters exercised their over-allotment option in full on March 13, 2020; thus, the 750,000 shares of Class B common stock were no longer subject to forfeiture. As of September 30, 2020 and December 31, 2019, there were 5,750,000 shares of Class B common stock issued outstanding. The Class B common stock will automatically convert into Class A common stock at the time of the Initial Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of shares of Class A common stock issuable upon conversion of all Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by Public Stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans, provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. Preferred Stock—The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. At September 30, 2020 and December 31, 2019, there are no shares of preferred stock issued or outstanding. Warrants—Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their Public Warrants on a cashless basis under certain circumstances). The Company has agreed that, as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its best efforts to file with the SEC and have declared effective a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrantholders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination and they will be non-redeemable for cash so long as they are held by the initial purchasers of the Private Placement Warrants or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers of the Private Placement Warrants or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the warrants included in the Units being sold in the Initial Public Offering. The Company may call the Public Warrants for redemption: <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> in whole and not in part;</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> at a price of $0.01 per warrant;</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> upon a minimum of 30 days’ prior written notice of redemption; and</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> if, and only if, the last reported sales price of the Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within the 30‑trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.</td></tr></table></div> If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. In addition, commencing ninety days after the warrants become exercisable, the Company may redeem the outstanding warrants for shares of Class A common stock: <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> in whole and not in part;</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities—Warrants—Public Stockholders’ Warrants” based on the redemption date and the “fair market value” of our Class A common stock (as defined below) except as otherwise described in “Description of Securities—Warrants—Public Stockholders’ Warrants”;</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> if, and only if, the last reported sale price of its Class A common stock equals or exceeds $10.00 per share (as adjusted per stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which it sends the notice of redemption to the warrant holders;</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> if, and only if, the Private Placement Warrants are also concurrently exchanged at the same price (equal to a number of shares of Class A common stock) as the outstanding Public Warrants, as described above; and</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30‑day period after written notice of redemption is given.</td></tr></table></div> The “fair market value” of the Company’s Class A common stock shall mean the average last reported sale price of its Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. This redemption feature differs from the typical warrant redemption features used in other blank check offerings. No fractional shares of Class A common stock will be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of shares of Class A common stock to be issued to the holder. Pursuant to the warrant agreement, references above to Class A common stock shall include a security other than Class A common stock into which the Class A common stock has been converted or exchanged for in the event the Company is not the surviving company in its initial Business Combination. In no event will the Company be required to net cash settle any warrant. If the Company does not complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. <div /></div> </div>

4312500

23000000

25000

230000000

229997700

2300

<div> <div> 8. Subsequent Events. Management has evaluated subsequent events and transactions that occurred after the balance sheet date up through the date the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. <div /></div> </div>

219898720

10.00

P5Y

23000000

5750000

23000000

5750000

EX-101.SCH 7 dfphu-20200930.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - CONDENSED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - CONDENSED STATEMENT OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Organization, Business Operations and Basis of Presentation - Financing (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Significant Accounting Policies - Net Loss Per Share of Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Initial Public Offering (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Related Party Transactions - Founder Shares (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Related Party Transactions - Private Placement Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 40403 - Disclosure - Related Party Transaction - Other Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Stockholders' Equity - Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - Stockholders' Equity - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Organization, Business Operations and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Initial Public Offering link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 40102 - Disclosure - Organization, Business Operations and Basis of Presentation - Trust Account (Details) link:presentationLink link:calculationLink link:definitionLink 40103 - Disclosure - Organization, Business Operations and Basis of Presentation - Liquidity (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Significant Accounting Policies - Concentration of Credit Risk, Cash and Cash Equivalents and Class A common stock subject to possible redemption (Details) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - Significant Accounting Policies - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Stockholders' Equity - Preferred Stock (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 dfphu-20200930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 dfphu-20200930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 dfphu-20200930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Information [Table] Class of Stock [Axis] Class Of Stock [Domain] Class of Stock [Domain] Represents the information pertaining to class A ordinary share and one fourth of one redeemable warrant. Class Ordinary Share And One Fourth Of One Redeemable Warrant [Member] Class A common stock and one-fourth of one redeemable warrant Common Class A [Member] Class A common stock Common Class B [Member] Class B common stock Represents the information pertaining to class A ordinary share. Warrant Exercisable For Class Ordinary Share [Member] Warrant exercisable for one share of Class A common stock Document Information [Line Items] Document Type Document Period End Date Entity Registrant Name Entity Central Index Key Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Title of 12(b) Security Trading Symbol Security Exchange Name CONDENSED BALANCE SHEETS Statement [Table] Statement [Line Items] Assets [Abstract] Assets: Assets, Current [Abstract] Current assets: Cash Prepaid expenses Prepaid expenses Assets, Current Total current assets Investments held in Trust Account Cash and investments held in Trust Account Deferred offering costs associated with initial public offering Deferred offering costs associated with initial public offering Total Assets Total assets Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity: Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered under related party transactions. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Liabilities, Current, Related Parties Accrued expenses - related parties Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to franchise tax. (due within one year or within the normal operating cycle if longer). Franchise Tax Payable, Current Franchise tax payable Total current liabilities Total current liabilities Carrying value as of the balance sheet date of deferred underwriting commissions incurred through that date and due after one year (or beyond the operating cycle if longer). Deferred underwriting commissions. Deferred underwriting commissions Deferred underwriting fees Total liabilities Total liabilities No definition available. Commitments [Abstract] Commitments and Contingencies Temporary Equity, Carrying Amount, Attributable to Parent Class A common stock, $0.0001 par value; 21,989,872 and -0- shares subject to possible redemption at $10.00 per share at September 30, 2020 and December 31, 2019, respectively Stockholders' Equity Attributable to Parent [Abstract] Stockholders' Equity: Common Stock, Value, Issued Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Total stockholders equity Ending balance Beginning balance Total stockholders' equity Total liabilities and stockholders? equity Total liabilities and stockholders' equity Shares subject to possible redemption under temporary equity arrangement. Temporary Equity, Shares Subject to Possible Redemption Temporary equity, shares subject to possible redemption Temporary Equity, Redemption Price Per Share Temporary equity, redemption price per share Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred shares, par value Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred shares, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred shares, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Preferred shares, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value Common shares, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common shares, shares authorized (in shares) Common Stock, Shares, Issued Common stock, shares issued Common shares, shares issued (in shares) Common Stock, Shares, Outstanding Common stock, shares outstanding Common shares, shares outstanding (in shares) Shares subject to possible redemption under common stock arrangement. Common Stock, Shares Subject to Possible Redemption Common stock, shares subject to possible redemption CONDENSED STATEMENTS OF OPERATIONS General and Administrative Expense General and administrative expenses Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party General and administrative expenses - related party Amount of franchise tax expense. Franchise Tax Expense Franchise tax expense Operating Income (Loss) Loss from operations Investment Income, Interest Interest earned on investments held in Trust Account Interest income from investments in Trust Account Interest income available in the Trust Account for tax obligations Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before income tax expense Income tax expense Income tax expense Net Income (Loss) Attributable to Parent Net loss Net loss Net loss Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted average shares outstanding Earnings Per Share, Basic and Diluted Basic and diluted net loss per share CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock [Member] Common Stock Additional Paid In Capital [Member] Additional Paid-In Capital Retained Earnings [Member] Accumulated Deficit Increase (Decrease) in Stockholders' Equity [Roll Forward] Changes in Stockholders' Equity Shares, Outstanding Ending balance (in shares) Beginning balance (in shares) Stock Issued During Period, Value, New Issues Sale of units in initial public offering Capital contribution Stock Issued During Period, Shares, New Issues Sale of units in initial public offering (in shares) Number of shares issued (in shares) Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Offering costs Adjustments to Additional Paid in Capital, Warrant Issued Sale of private placement warrants to Sponsor in private placement Equity impact of the value of common stock subject to possible redemption. Common Stock Subject to Possible Redemption, Value Common stock subject to possible redemption Equity impact of the shares of common stock subject to possible redemption. Common Stock Subject to Possible Redemption, Shares Common stock subject to possible redemption (in shares) CONDENSED STATEMENT OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Cash Flows from Operating Activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense Prepaid expenses Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities Accrued expenses The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid pertaining to related parties. Increase (Decrease) in Accrued Liabilities, Related Parties Accrued expenses - related parties The increase (decrease) during the reporting period of franchise tax payable. Increase (Decrease) in Franchise Tax Payable Franchise tax payable Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Cash Flows from Investing Activities The cash outflow for the purchase of investments that will be held in a trust account. Payments to Acquire Investments to be Held in Trust Account Principal deposited in Trust Account Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Cash Flows from Financing Activities: Proceeds from Related Party Debt Proceeds received from note payable to related party Repayments of Related Party Debt Repayment of note payable to related party Proceeds from Issuance Initial Public Offering Proceeds received from initial public offering, gross Proceeds from Issuance of Private Placement Proceeds received from private placement Payments of Stock Issuance Costs Offering costs paid Offering costs Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net increase in cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash - end of the period Cash - beginning of the period Supplemental Cash Flow Information [Abstract] Supplemental disclosure of noncash activities: The amount of deferred underwriting commissions with initial public offering that were incurred during a noncash or partial noncash transaction. Deferred Underwriting Commissions in Connection with Initial Public Offering Deferred underwriting commissions in connection with the initial public offering The amount of common stock subject to possible redemption during a noncash or partial noncash transaction. Common Stock Subject to Possible Redemption, Noncash Initial value of Class A common stock subject to possible redemption Amount of change in value of common stock subject to possible redemption. Change In Value Of Common Stock Subject To Possible Redemption Change in value of Class A common stock subject to possible redemption Organization, Business Operations and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization, Business Operations and Basis of Presentation Significant Accounting Policies Significant Accounting Policies [Text Block] Significant Accounting Policies No definition available. Initial Public Offering The entire disclosure on information about public offering. Public Offering [Text Block] Initial Public Offering Related Party Transactions Related Party Transactions Disclosure [Text Block] Related Party Transactions Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Stockholders Equity Stockholders' Equity Note Disclosure [Text Block] Stockholders Equity Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Subsequent Events Subsequent Events [Text Block] Subsequent Events Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Marketable Securities, Policy [Policy Text Block] Investments Held in Trust Account Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Represents the accounting policy on offering costs. Offering Costs [Policy Text Block] Offering Costs Represents the accounting policy on common stock subject to possible redemption. Common Stock Subject to Possible Redemption [Policy Text Block] Class A Common Stock Subject to Possible Redemption Earnings Per Share, Policy [Policy Text Block] Net Loss Per Share of Common Stock Income Tax, Policy [Policy Text Block] Income Taxes New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Fair Value, Assets Measured on Recurring Basis [Table Text Block] Schedule of Company's assets that are measured at fair value on a recurring basis Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Sale of Stock [Axis] Sale Of Stock Name Of Transaction [Domain] Sale of Stock [Domain] I P O [Member] Public Offering Private Placement [Member] Private Placement Over Allotment Option [Member] Over-allotment Subsidiary, Sale of Stock [Line Items] Number of new units issued during the period. Units Issued During Period, Shares, New Issues Number of shares issued Additional units issued Share Price Share price Price per unit Proceeds from Issuance or Sale of Equity Proceeds from issuance of shares Amount of unrecognized fee revenue received from underwriting that is deferred. Deferred Underwriting Commissions Deferred underwriting commissions Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of warrants to purchase shares issued (in shares) Price per share or per unit of warrants or rights outstanding. Class of Warrant or Right, Price of Warrants or Rights Price of warrants Proceeds from Issuance of Warrants Proceeds from issuance of warrants Represents the principal amount deposited in trust account. Principal Amount Deposited In Trust Account Principal deposited in Trust Account Represents the obligation to redeem percentage of common stock with respect to any other material provision relating to stockholders' rights or pre-initial Business Combination activity. Obligation to redeem Percentage of Common Stock With Respect To Any Other Material Provision Relating To Stockholders' Rights Or Pre-Initial Business Combination Activity Represents the Redemption of percentage of common stock included in the units being sold in the public offering. Redemption Of Percentage of Common Stock Included in Units Sold in Offering Redemption of common stock included in the units sold in public offering (as a percent) Represents the threshold period from closing of public offering the company is obligated to complete business combination. Threshold Period From Closing of Public Offering the Entity is Obligated to Complete Business Combination Threshold period from closing of public offering the company is obligated to complete business combination Represents the cash equal to pro rata share calculated based on number of business days prior to consummation of business combination. Cash Equal To Pro Rata Share Calculated Based On Number Of Business Days Prior To Consummation Of Business Combination Cash equal to pro rata share calculated based on business days prior to consummation of business combination (in days) Represents the cash equal to pro rata share calculated based on number of business days prior to consummation of tender offer. Cash Equal To Pro Rata Share Calculated Based On Number Of Business Days Prior To Consummation Of Tender Offer Cash equal to pro rata share calculated based on business days prior to consummation of tender offer (in days) Represents the minimum net tangible assets upon consummation of the Company's initial Business Combination and after payment of underwriters fees and commissions. Minimum Net Tangible Assets Minimum net tangible assets upon consummation of the Company's initial Business Combination and after payment of underwriters fees and commissions Represents the threshold business days for redemption of shares of trust account. Threshold Business Days for Redemption of Shares of Trust Account Threshold business days for redemption of shares of trust account Represents the maximum net interest to pay dissolution expenses. Maximum Net Interest to Pay Dissolution Expenses Maximum net interest to pay dissolution expenses Represents the minimum net interest to pay dissolution expenses. Minimum Net Interest to Pay Dissolution Expenses Minimum net interest to pay dissolution expenses Cash and Cash Equivalents, at Carrying Value Operating bank account Represents the amount of working capital as of balance sheet date. Working Capital Working capital Contribution from sponsor. Contribution From Sponsor Contribution from sponsor Notes from sponsor. Notes From Sponsor Note from sponsor Represents the amount of working capital loans as of balance sheet date. Working Capital Loan Amounts outstanding under any Working Capital Loan Represents the amount of cash equivalents held in the Trust Account. Cash Equivalents Held In The Trust Account Cash equivalents held in the Trust Account Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares Shares subject to possible redemption Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities Name [Domain] Antidilutive Securities, Name [Domain] Warrant [Member] Private placement warrants Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Shares excluded since their inclusion would be anti-dilutive Represents the minimum allowance for tax obligations. Minimum Allowance For Tax Obligations Minimum allowance for tax obligations Represents the maximum allowance for tax obligations. Maximum Allowance For Tax Obligations Maximum allowance for tax obligations Distributed Earnings Income attributable to Class A common stock Net Income (Loss) Available to Common Stockholders, Basic Net loss after distributed earnings Deferred Tax Assets, Net of Valuation Allowance Deferred tax asset Unrecognized Tax Benefits Unrecognized tax benefits Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Amounts accrued for the payment of interest and penalties The percentage of change in income tax rate due to start up costs. Percentage Change In Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Percent Effective tax rates Counterparty Name [Axis] Repurchase Agreement Counterparty Name [Domain] Counterparty Name [Domain] Represents information pertaining to Deerfield Management Company, L.P. Deerfield Management Company L.p [Member] Deerfield Funds EX-101.PRE 11 dfphu-20200930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2020	Nov. 13, 2020
Document Information [Line Items]
Document Type	10-Q
Document Period End Date	Sep. 30, 2020
Entity Registrant Name	DFP HEALTHCARE ACQUISITIONS CORP.
Entity Central Index Key	0001799191
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A common stock and one-fourth of one redeemable warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
Trading Symbol	DFPHU
Security Exchange Name	NASDAQ
Class A common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		23,000,000
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	DFPH
Security Exchange Name	NASDAQ
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		5,750,000
Warrant exercisable for one share of Class A common stock
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
Trading Symbol	DFPHW
Security Exchange Name	NASDAQ

XML 13 R2.htm IDEA: XBRL DOCUMENT

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash	$ 998,571	$ 25,000
Prepaid expenses	202,187
Total current assets	1,200,758	25,000
Cash and investments held in Trust Account	230,194,901
Deferred offering costs associated with initial public offering		25,000
Total assets	231,395,659	50,000
Current liabilities:
Accounts payable	1,329
Accrued expenses	28,000	26,500
Accrued expenses - related parties	17,500
Franchise tax payable	150,100	800
Total current liabilities	196,929	27,300
Deferred underwriting commissions	6,300,000
Total liabilities	6,496,929	27,300
Commitments and Contingencies
Class A common stock, $0.0001 par value; 21,989,872 and -0- shares subject to possible redemption at $10.00 per share at September 30, 2020 and December 31, 2019, respectively	219,898,720
Stockholders' Equity:
Additional paid-in capital	5,300,118	24,425
Accumulated deficit	(300,784)	(2,300)
Total stockholders' equity	5,000,010	22,700
Total liabilities and stockholders' equity	231,395,659	50,000
Class A common stock
Stockholders' Equity:
Common Stock, Value, Issued	101
Class B common stock
Stockholders' Equity:
Common Stock, Value, Issued	$ 575	$ 575

XML 14 R3.htm IDEA: XBRL DOCUMENT

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares outstanding	5,750,000	5,750,000
Class A common stock
Temporary equity, shares subject to possible redemption	21,989,872	0
Temporary equity, redemption price per share	$ 10.00	$ 10.00
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	1,010,128	0
Common stock, shares outstanding	1,010,128	0
Common stock, shares subject to possible redemption	21,989,872	0
Class B common stock
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	5,750,000	5,750,000
Common stock, shares outstanding	5,750,000	5,750,000

XML 15 R4.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended	9 Months Ended
CONDENSED STATEMENTS OF OPERATIONS - USD ($)	Sep. 30, 2020	Sep. 30, 2020
General and administrative expenses	$ 95,980	$ 208,562
General and administrative expenses - related party	52,500	122,500
Franchise tax expense	50,000	149,750
Loss from operations	(198,480)	(480,812)
Interest income from investments in Trust Account	73,393	194,901
Loss before income tax expense	(125,087)	(285,911)
Income tax expense	12,573	12,573
Net loss	(137,660)	(298,484)
Class A common stock
Interest income from investments in Trust Account	$ 74,000	$ 195,000
Weighted average shares outstanding	23,000,000	23,000,000
Class B common stock
Net loss	$ (138,000)	$ (298,000)
Weighted average shares outstanding	5,750,000	5,750,000
Basic and diluted net loss per share	$ (0.02)	$ (0.05)

XML 16 R5.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Common Stock Class A common stock	Common Stock Class B common stock	Additional Paid-In Capital	Accumulated Deficit	Class B common stock	Total
Beginning balance at Dec. 31, 2019		$ 575	$ 24,425	$ (2,300)		$ 22,700
Beginning balance (in shares) at Dec. 31, 2019		5,750,000
Changes in Stockholders' Equity
Sale of units in initial public offering	$ 2,300		229,997,700			230,000,000
Sale of units in initial public offering (in shares)	23,000,000
Offering costs			(10,425,486)			(10,425,486)
Sale of private placement warrants to Sponsor in private placement			5,600,000			5,600,000
Common stock subject to possible redemption	$ (2,202)		(220,149,918)			(220,152,120)
Common stock subject to possible redemption (in shares)	(22,015,212)
Net loss				(45,089)		(45,089)
Ending balance at Mar. 31, 2020	$ 98	$ 575	5,046,721	(47,389)		5,000,005
Ending balance (in shares) at Mar. 31, 2020	984,788	5,750,000
Beginning balance at Dec. 31, 2019		$ 575	24,425	(2,300)		22,700
Beginning balance (in shares) at Dec. 31, 2019		5,750,000
Changes in Stockholders' Equity
Net loss					$ (298,000)	(298,484)
Ending balance at Sep. 30, 2020	$ 101	$ 575	5,300,118	(300,784)		5,000,010
Ending balance (in shares) at Sep. 30, 2020	1,010,128	5,750,000
Beginning balance at Mar. 31, 2020	$ 98	$ 575	5,046,721	(47,389)		5,000,005
Beginning balance (in shares) at Mar. 31, 2020	984,788	5,750,000
Changes in Stockholders' Equity
Common stock subject to possible redemption	$ 2		115,738			115,740
Common stock subject to possible redemption (in shares)	11,574
Net loss				(115,735)		(115,735)
Ending balance at Jun. 30, 2020	$ 100	$ 575	5,162,459	(163,124)		5,000,010
Ending balance (in shares) at Jun. 30, 2020	996,362	5,750,000
Changes in Stockholders' Equity
Common stock subject to possible redemption	$ 1		137,659			137,660
Common stock subject to possible redemption (in shares)	13,766
Net loss				(137,660)	$ (138,000)	(137,660)
Ending balance at Sep. 30, 2020	$ 101	$ 575	$ 5,300,118	$ (300,784)		$ 5,000,010
Ending balance (in shares) at Sep. 30, 2020	1,010,128	5,750,000

XML 17 R6.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENT OF CASH FLOWS	9 Months Ended
CONDENSED STATEMENT OF CASH FLOWS	Sep. 30, 2020 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (298,484)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on investments held in Trust Account	(194,901)
Changes in operating assets and liabilities:
Prepaid expenses	(202,187)
Accounts payable	1,329
Accrued expenses	26,500
Accrued expenses - related parties	17,500
Franchise tax payable	149,300
Net cash used in operating activities	(500,943)
Cash Flows from Investing Activities
Principal deposited in Trust Account	(230,000,000)
Net cash used in investing activities	(230,000,000)
Cash Flows from Financing Activities:
Proceeds received from note payable to related party	200,000
Repayment of note payable to related party	(200,000)
Proceeds received from initial public offering, gross	230,000,000
Proceeds received from private placement	5,600,000
Offering costs paid	(4,125,486)
Net cash provided by financing activities	231,474,514
Net increase in cash	973,571
Cash - beginning of the period	25,000
Cash - end of the period	998,571
Supplemental disclosure of noncash activities:
Deferred underwriting commissions in connection with the initial public offering	6,300,000
Initial value of Class A common stock subject to possible redemption	220,164,430
Change in value of Class A common stock subject to possible redemption	$ (265,710)

XML 18 R7.htm IDEA: XBRL DOCUMENT

Organization, Business Operations and Basis of Presentation	9 Months Ended
	Sep. 30, 2020
Organization, Business Operations and Basis of Presentation
Organization, Business Operations and Basis of Presentation	1. Organization, Business Operations and Basis of Presentation. Incorporation DFP Healthcare Acquisitions Corp. (the “Company”) was incorporated as a Delaware corporation on November 1, 2019. Sponsor The Company’s sponsor is DFP Sponsor LLC, a Delaware limited liability company (the “Sponsor”). Fiscal Year End The Company has selected December 31 as its fiscal year end. Business Purpose The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more operating businesses that it has not yet selected (“Business Combination”). The Company has neither engaged in any operations nor generated revenue to date. As of September 30, 2020, the Company had not commenced any operations. All activity for the period from November 1, 2019 (inception) through September 30, 2020 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and since the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering, although substantially all of the net proceeds of the Initial Public Offering are intended to be generally applied toward completing a Business Combination. Furthermore, there is no assurance that the Company will be able to successfully complete a Business Combination. Financing The registration statement for the Company’s Initial Public Offering was declared effective by the Securities and Exchange Commission (the “SEC”) on March 10, 2020. On March 13, 2020, the Company consummated its Initial Public Offering of 23,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), including 3,000,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $10.4 million, inclusive of approximately $6.3 million in deferred underwriting commissions (Note 3). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 3,733,334 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor, generating proceeds of $5.6 million (Note 4). Trust Account Upon the closing of the Initial Public Offering and the Private Placement, $230.00 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (the “Trust Account”) and invested in permitted United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, which the Company refers to as the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a‑7 promulgated under the Investment Company Act that invest only in direct U.S. government treasury obligations. The Company’s second amended and restated certificate of incorporation provides that, other than the withdrawal of interest earned on the funds that may be released to the Company to pay taxes, none of the funds held in Trust Account will be released until the earlier of: (i) the completion of the Business Combination; (ii) the redemption of the Public Shares to its holders (the “Public Stockholders”) properly tendered in connection with a stockholder vote to amend the Company’s second amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares or with respect to any other material provision relating to stockholders’ rights or pre-initial Business Combination activity, or (iii) the redemption of 100% of the Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering. The Company, after signing a definitive agreement for a Business Combination, will either (i) seek stockholder approval of the Business Combination at a meeting called for such purpose in connection with which stockholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to fund its working capital requirements (subject to an annual limit of $500,000) and/or to pay its taxes, or (ii) provide the Public Stockholders with the opportunity to sell their shares to the Company by means of a tender offer for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to commencement of the tender offer, including interest earned on the funds held in the Trust Account and not previously released to the Company to fund its working capital requirements (subject to an annual limit of $500,000) and/or to pay taxes. The decision as to whether the Company will seek stockholder approval of the Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the outstanding shares of common stock voted are voted in favor of the Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. If the Company holds a stockholder vote in connection with a Business Combination, a Public Stockholder will have the right to redeem its shares for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to fund its working capital requirements (subject to an annual limit of $500,000) and/or to pay its taxes. As a result, such common stock is recorded at redemption amount and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with FASB, ASC 480, “Distinguishing Liabilities from Equity.” The amount in the Trust Account is initially anticipated to be $10.00 per public share ($230.0 million held in the Trust Account divided by 23,000,000 public shares). The Company will have 24 months from the closing of the Initial Public Offering, or until March 13, 2022, to complete its initial Business Combination (the “ Combination Period”). If the Company does not complete a Business Combination within this period of time, it will (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares for a per share pro rata portion of the Trust Account, including interest and not previously released to the Company to fund its working capital requirements (subject to an annual limit of $500,000) (less taxes payable and up to $100,000 of such net interest to pay dissolution expenses) and (iii) as promptly as possible following such redemption, liquidate and dissolve the balance of the Company’s net assets to its remaining stockholders, as part of its plan of dissolution and liquidation. The Sponsor and the Company’s officers and directors (the “initial stockholders”) have entered into a letter agreement with the Company, pursuant to which they have waived their rights to participate in any redemption with respect to their Founder Shares (as defined below); however, if the initial stockholders acquire shares of common stock in or after the Initial Public Offering, they will be entitled to a pro rata share of the Trust Account upon the Company’s redemption of common stock or liquidation in the event the Company does not complete a Business Combination within the required time period. In the event of such a liquidating distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial price per Unit in the Initial Public Offering. Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected through December 31, 2020 or any future period. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the final prospectus and the Form 8‑K filed by the Company with the SEC on March 12, 2020 and March 19, 2020, respectively. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accountant standards used. Liquidity As of September 30, 2020, the Company had approximately $1.0 million in its operating bank account, working capital of approximately $1.0 million, and approximately $195,000 of interest income available in the Trust Account for working capital requirements (subject to an annual limit of $500,000) and/or to pay for the Company’s tax obligations, if any. The Company’s liquidity needs to date have been satisfied through a $25,000 contribution from the Sponsor in exchange for the issuance of the Founder Shares to the Sponsor, the Note (defined below) of $200,000 from the Sponsor, and the proceeds from the consummation of the Private Placement not held in the Trust Account. On March 13, 2020, the Company repaid the Note in full to the Sponsor. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company with Working Capital Loans (see Note 4). As of September 30, 2020, there were no Working Capital Loans outstanding. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

XML 19 R8.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies

9 Months Ended

Sep. 30, 2020

Significant Accounting Policies

Significant Accounting Policies

2. Significant Accounting Policies.

Use of Estimates

The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company's management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future conforming events. Accordingly, the actual results could differ from those estimates.

Cash and Cash Equivalents

Investments Held in Trust Account

Concentration of Credit Risk

Fair Value of Financial Instruments

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

Offering Costs

The Company complies with the requirements of the ASC 340‑10‑S99‑1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering, and were charged to stockholders’ equity upon the completion of the Initial Public Offering.

Class A Common Stock Subject to Possible Redemption

Net Loss Per Share of Common Stock

Income Taxes

The Company’s currently taxable income primarily consists of interest income on the Trust Account,less any franchise taxes. The Company’s formation and operating costs are generally considered start-up costs and are not currently deductible. During the three and nine months ended September 30, 2020, the Company recorded $12,573 of income tax expense. The Company’s effective tax rates for three and nine months ended September 30, 2020 were negative (10%) and (4%), respectively, which differ from the expected income tax rate due to start-up costs (discussed above) which are not currently deductible.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

XML 20 R9.htm IDEA: XBRL DOCUMENT

Initial Public Offering	9 Months Ended
Initial Public Offering	Sep. 30, 2020
Initial Public Offering
Initial Public Offering	3. Initial Public Offering. Public Units On March 13, 2020, the Company consummated its Initial Public Offering of 23,000,000 Units, including 3,000,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $10.4 million, inclusive of approximately $6.3 million in deferred underwriting commissions. Of the Units sold in the Initial Public Offering, 5,000,000 Units were purchased by certain domestic private pooled investment vehicles managed by Deerfield Management Company, L.P. and its affiliates (the “Deerfield Funds”). Each Unit consists of one of the Company’s shares of Class A common stock, $0.0001 par value, and one-fourth of one redeemable warrant (the “Warrants”). Each whole Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share. The exercise price and number of shares of Class A common stock issuable upon exercise of the Warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Related Party Transactions	9 Months Ended
Related Party Transactions	Sep. 30, 2020
Related Party Transactions
Related Party Transactions	4. Related Party Transactions. Founder Shares On December 30, 2019, the Sponsor received 4,312,500 shares of Class B common stock (the “Founder Shares”) in exchange for a capital contribution of $25,000, or approximately $0.004 per share. In January 2020, the Sponsor transferred 100,000 Founder Shares to each of Steven Hochberg, the Company’s President and Chief Executive Officer, Christopher Wolfe, the Company’s Chief Financial Officer and Secretary, and Richard Barasch, the Company’s Executive Chairman, and 30,000 Founder Shares to each of Dr. Jennifer Carter, Dr. Mohit Kaushal and Dr. Gregory Sorensen, the Company’s independent director nominees, for the same per-share price initially paid by the Sponsor, resulting in the Sponsor holding 3,922,500 Founder Shares. On February 19, 2020, the Company effected a split of its Class B common stock resulting in the Sponsor holding 5,360,000 Founder Shares, resulting in an increase in the total number of Founder Shares from 4,312,500 to 5,750,000. Of the 5,750,000 Founder Shares, up to 750,000 shares were subject to forfeiture by the initial stockholders depending on the exercise of the underwriters’ over-allotment option. The underwriters exercised their over-allotment option in full on March 13, 2020; thus, the Founder Shares are no longer subject to forfeiture. The Founder Shares are identical to the shares of Class A common stock included in the Units being sold in the Initial Public Offering except that the Founder Shares are subject to certain transfer restrictions. The initial stockholders have agreed not to transfer, assign or sell any of their Founder Shares until the earlier of (A) one year after the completion of the Company’s initial Business Combination, or earlier if, subsequent to the Company’s initial Business Combination, the closing price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30‑trading day period commencing at least 150 days after the Company’s initial Business Combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the initial Business Combination that results in all of the Company’s stockholders having the right to exchange their common stock for cash, securities or other property. Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company sold 3,733,334 Private Placement Warrants to the Sponsor at a price of $1.50 per Private Placement Warrant in a Private Placement, generating proceeds of $5.6 million. Each Private Placement Warrant entitles the holder to purchase one share of Class A common stock at $11.50 per share. Certain proceeds of the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination, the proceeds of the Private Placement will be part of the liquidating distribution to the Public Stockholders and the Warrants issued to the Sponsor will expire worthless. Sponsor Loans The Sponsor agreed to loan the Company up to an aggregate of $200,000 by the issuance of an unsecured promissory note (the “Note”) to cover expenses related to this Initial Public Offering. The Note was payable without interest upon the completion of the Initial Public Offering. The Company received the $200,000 proceeds under the Note and repaid this Note in full on March 13, 2020. Administrative Services Agreement Commencing on the date that the Company’s securities were first listed on Nasdaq, the Company has paid and will pay the Sponsor $10,000 per month for office space, secretarial and administrative services provided to members of the Company’s management team. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying such monthly fees. The Company incurred $30,000 and $70,000 in expenses in connection with such services during the three and nine months ended September 30, 2020, respectively, as included in general and administrative expenses - related party on the accompanying unaudited condensed statements of operations. As of September 30, 2020 and December 31, 2019, the Company had $10,000 and $0 in connection with such services in accrued expenses to related parties, respectively, as included in the accompanying unaudited condensed balance sheets. Wolfe Strategic Services Agreement Commencing on the date that the Company’s securities were first listed on Nasdaq, the Company will pay and has paid its Chief Financial Officer, Christopher Wolfe, $7,500 per month for his services prior to the initial Business Combination. The Company incurred $22,500 and $52,500 in expenses in connection with such services during the three and nine months ended September 30, 2020, respectively, included in general and administrative expenses - related party on the accompanying unaudited condensed statement of operations. As of September 30, 2020, and December 31, 2019, the Company had $7,500 and $0 in connection with such services in accrued expenses to related parties, respectively, as included in the accompanying unaudited condensed balance sheets. Working Capital Loans In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required for working capital (the “Working Capital Loans”). Up to $1.1 million of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. As of September 30, 2020, except for the foregoing, the terms of such loans, if any, have not been determined, no written agreements exist with respect to such loans and no amounts have been borrowed under such loans to date.

XML 22 R11.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2020
Commitments and Contingencies
Commitments and Contingencies	5. Commitments and Contingencies. Registration Rights The initial stockholders and holders of the Private Placement Warrants are entitled to registration rights pursuant to a registration rights agreement. The initial stockholders and holders of the Private Placement Warrants will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by the Company. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option to purchase up to 3,000,000 additional Units to cover any over-allotments, at the initial public offering price less the underwriting discounts and commissions. The warrants that were issued in connection with the 3,000,000 over-allotment Units are identical to the public warrants and have no net cash settlement provisions. The underwriters exercised the over-allotment option in full on March 13, 2020. The underwriters did not receive any underwriting discounts or commission on the Units purchased by the Deerfield Funds. The Company paid an underwriting discount of 2.0% of the per Unit offering price, or $3.6 million, at the closing of the Initial Public Offering, with an additional fee (the “Deferred Underwriting Fees”) of 3.5% of the gross offering proceeds, or $6.3 million, payable upon the Company's completion of an Initial Business Combination. The Deferred Underwriting Fees will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes its initial Business Combination. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on its industry and has concluded that, while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

XML 23 R12.htm IDEA: XBRL DOCUMENT

Stockholders' Equity

9 Months Ended

Sep. 30, 2020

Stockholders Equity

Stockholders Equity

6. Stockholders’ Equity.

Class A Common Stock—The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of December 31, 2019, there were no shares of Class A common stock issued or outstanding. As of September 30, 2020, there were 23,000,000 shares of Class A common stock issued or outstanding, including 21,989,872 shares of Class A common stock subject to possible redemption.

Class B Common Stock—The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of the Company’s Class B common stock are entitled to one vote for each share. On December 30, 2019, the Company initially issued 4,312,500 shares of Class B common stock. On February 19, 2020, in connection with the proposed increase of the size of the Initial Public Offering, the Company effected a split of its Class B common stock resulting in the Sponsor holding 5,360,000 Founder Shares and an increase in the total number of Class B common stock outstanding from 4,312,500 to 5,750,000. Of the 5,750,000 shares of Class B common stock outstanding, up to 750,000 shares were subject to forfeiture to the Company to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the initial stockholders would collectively own 20% of the Company’s issued and outstanding common stock after the Initial Public Offering. The underwriters exercised their over-allotment option in full on March 13, 2020; thus, the 750,000 shares of Class B common stock were no longer subject to forfeiture. As of September 30, 2020 and December 31, 2019, there were 5,750,000 shares of Class B common stock issued outstanding.

Preferred Stock—The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. At September 30, 2020 and December 31, 2019, there are no shares of preferred stock issued or outstanding.

Warrants—Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their Public Warrants on a cashless basis under certain circumstances). The Company has agreed that, as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its best efforts to file with the SEC and have declared effective a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrantholders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company may call the Public Warrants for redemption:

in whole and not in part;

at a price of $0.01 per warrant;

upon a minimum of 30 days’ prior written notice of redemption; and

if, and only if, the last reported sales price of the Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within the 30‑trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

In addition, commencing ninety days after the warrants become exercisable, the Company may redeem the outstanding warrants for shares of Class A common stock:

in whole and not in part;

at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities—Warrants—Public Stockholders’ Warrants” based on the redemption date and the “fair market value” of our Class A common stock (as defined below) except as otherwise described in “Description of Securities—Warrants—Public Stockholders’ Warrants”;

if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30‑day period after written notice of redemption is given.

The “fair market value” of the Company’s Class A common stock shall mean the average last reported sale price of its Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. This redemption feature differs from the typical warrant redemption features used in other blank check offerings.

In no event will the Company be required to net cash settle any warrant. If the Company does not complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

XML 24 R13.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

9 Months Ended

Sep. 30, 2020

Fair Value Measurements

Fair Value Measurements

7. Fair Value Measurements.

September 30, 2020


	Quoted Prices in		Significant Other		Significant Other
	Active Markets		Observable Inputs		Unobservable Inputs
Description	(Level 1)		(Level 2)		(Level 3)
Assets held in Trust Account:
U.S. Treasury securities	$	230,173,491	$	—	$	—
Cash and Cash equivalents	$	21,410
	$	230,194,901	$	—	$	—

Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels for the three and nine months ended September 30, 2020.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 25 R14.htm IDEA: XBRL DOCUMENT

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2020
Subsequent Events
Subsequent Events	8. Subsequent Events. Management has evaluated subsequent events and transactions that occurred after the balance sheet date up through the date the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

XML 26 R15.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2020

Significant Accounting Policies

Use of Estimates

Cash and Cash Equivalents

Investments Held in Trust Account

Concentration of Credit Risk

Fair Value of Financial Instruments

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

Offering Costs

Class A Common Stock Subject to Possible Redemption

Net Loss Per Share of Common Stock

Income Taxes

The Company’s currently taxable income primarily consists of interest income on the Trust Account,less any franchise taxes. The Company’s formation and operating costs are generally considered start-up costs and are not currently deductible. During the three and nine months ended September 30, 2020, the Company recorded $12,573 of income tax expense. The Company’s effective tax rates for three and nine months ended September 30, 2020 were negative (10%) and (4%), respectively, which differ from the expected income tax rate due to start-up costs (discussed above) which are not currently deductible.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

XML 27 R16.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2020

Fair Value Measurements

Schedule of Company's assets that are measured at fair value on a recurring basis


	Quoted Prices in		Significant Other		Significant Other
	Active Markets		Observable Inputs		Unobservable Inputs
Description	(Level 1)		(Level 2)		(Level 3)
Assets held in Trust Account:
U.S. Treasury securities	$	230,173,491	$	—	$	—
Cash and Cash equivalents	$	21,410
	$	230,194,901	$	—	$	—

XML 28 R17.htm IDEA: XBRL DOCUMENT

Organization, Business Operations and Basis of Presentation - Financing (Details) - USD ($)		9 Months Ended
	Mar. 13, 2020	Sep. 30, 2020
Subsidiary, Sale of Stock [Line Items]
Share price		$ 10.00
Offering costs		$ 4,125,486
Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of shares issued	23,000,000
Share price	$ 10.00
Proceeds from issuance of shares	$ 230,000,000
Offering costs	10,400,000
Deferred underwriting commissions	$ 6,300,000,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued (in shares)		3,733,334
Price of warrants		$ 1.50
Proceeds from issuance of warrants		$ 5,600,000
Over-allotment
Subsidiary, Sale of Stock [Line Items]
Number of shares issued	3,000,000

XML 29 R18.htm IDEA: XBRL DOCUMENT

Organization, Business Operations and Basis of Presentation - Trust Account (Details)	9 Months Ended
	Sep. 30, 2020 USD ($) $ / shares
Organization, Business Operations and Basis of Presentation
Principal deposited in Trust Account	$ 230,000,000
Obligation to redeem Percentage of Common Stock With Respect To Any Other Material Provision Relating To Stockholders' Rights Or Pre-Initial Business Combination Activity	100.00%
Redemption of common stock included in the units sold in public offering (as a percent)	100.00%
Threshold period from closing of public offering the company is obligated to complete business combination	24 months
Cash equal to pro rata share calculated based on business days prior to consummation of business combination (in days)	2 days
Cash equal to pro rata share calculated based on business days prior to consummation of tender offer (in days)	2 days
Minimum net tangible assets upon consummation of the Company's initial Business Combination and after payment of underwriters fees and commissions	$ 5,000,001
Share price \| $ / shares	$ 10.00
Threshold business days for redemption of shares of trust account	10 days
Maximum net interest to pay dissolution expenses	$ 500,000
Minimum net interest to pay dissolution expenses	$ 100,000

XML 30 R19.htm IDEA: XBRL DOCUMENT

Organization, Business Operations and Basis of Presentation - Liquidity (Details)	3 Months Ended	9 Months Ended
	Sep. 30, 2020 USD ($)	Sep. 30, 2020 USD ($)
Organization, Business Operations and Basis of Presentation
Operating bank account	$ 1,000,000	$ 1,000,000
Working capital		1,000,000
Interest income from investments in Trust Account	73,393	194,901
Maximum net interest to pay dissolution expenses		500,000
Contribution from sponsor		25,000
Note from sponsor		200,000
Amounts outstanding under any Working Capital Loan	$ 0	$ 0

XML 31 R20.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies - Concentration of Credit Risk, Cash and Cash Equivalents and Class A common stock subject to possible redemption (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Significant Accounting Policies
Cash equivalents held in the Trust Account	$ 0
Shares subject to possible redemption	21,989,872	0

XML 32 R21.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies - Net Loss Per Share of Common Stock (Details) - USD ($)	3 Months Ended			9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Interest income available in the Trust Account for tax obligations	$ 73,393			$ 194,901
Working capital				1,000,000
Net loss	137,660	$ 115,735	$ 45,089	298,484
Class A common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Interest income available in the Trust Account for tax obligations	74,000			195,000
Minimum allowance for tax obligations	63,000
Maximum allowance for tax obligations				162,000
Working capital	11,000			33,000
Class B common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net loss	138,000			298,000
Income attributable to Class A common stock				0
Net loss after distributed earnings	$ 138,000			$ 298,000
Private placement warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded since their inclusion would be anti-dilutive				9,483,334

XML 33 R22.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies - Income Taxes (Details) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2019
Significant Accounting Policies
Deferred tax asset	$ 70,000	$ 70,000	$ 300
Unrecognized tax benefits	0	0
Amounts accrued for the payment of interest and penalties	0	0
Income tax expense	$ 12,573	$ 12,573
Effective tax rates	(10.00%)	(4.00%)

XML 34 R23.htm IDEA: XBRL DOCUMENT

Initial Public Offering (Details) - USD ($)		9 Months Ended
Initial Public Offering (Details) - USD ($)	Mar. 13, 2020	Sep. 30, 2020	Dec. 31, 2019
Subsidiary, Sale of Stock [Line Items]
Price per unit		$ 10.00
Offering costs		$ 4,125,486
Deferred underwriting commissions in connection with the initial public offering		$ 6,300,000
Deerfield Funds
Subsidiary, Sale of Stock [Line Items]
Additional units issued	5,000,000
Class A common stock
Subsidiary, Sale of Stock [Line Items]
Number of shares in a unit	1
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Number of warrants in a unit	0.25
Number of shares issuable per warrant	1
Exercise price of warrants (in dollars per share)	$ 11.50
Public Offering
Subsidiary, Sale of Stock [Line Items]
Additional units issued	23,000,000
Price per unit	$ 10.00
Proceeds from issuance of shares	$ 230,000,000
Offering costs	10,400,000
Deferred underwriting commissions in connection with the initial public offering	$ 6,300,000
Over-allotment
Subsidiary, Sale of Stock [Line Items]
Additional units issued	3,000,000

XML 35 R24.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Founder Shares (Details) - USD ($)			1 Months Ended	3 Months Ended	9 Months Ended
	Feb. 19, 2020	Dec. 30, 2019	Jan. 31, 2020	Mar. 31, 2020	Sep. 30, 2020
Related Party Transaction [Line Items]
Capital contribution				$ 230,000,000
Class B common stock
Related Party Transaction [Line Items]
Total number of shares after stock split (in shares)	5,750,000
Number of shares subject to forfeiture (in shares)	750,000
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination					1 year
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)					$ 12.00
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination					20 days
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination					30 days
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences					150 days
Class B common stock \| Sponsor
Related Party Transaction [Line Items]
Number of shares issued (in shares)		4,312,500
Capital contribution		$ 25,000
Capital contribution (in dollars per share)		$ 0.004
Number of shares held (in shares)			3,922,500
Number of shares held after stock split (in shares)	5,360,000
Class B common stock \| Sponsor \| Steven Hochberg
Related Party Transaction [Line Items]
Number of shares transferred (in shares)			100,000
Class B common stock \| Sponsor \| Christopher Wolfe
Related Party Transaction [Line Items]
Number of shares transferred (in shares)			100,000
Class B common stock \| Sponsor \| Richard Barasch
Related Party Transaction [Line Items]
Number of shares transferred (in shares)			100,000
Class B common stock \| Sponsor \| Dr. Jennifer Carter
Related Party Transaction [Line Items]
Number of shares transferred (in shares)			30,000
Class B common stock \| Sponsor \| Dr. Mohit Kaushal
Related Party Transaction [Line Items]
Number of shares transferred (in shares)			30,000
Class B common stock \| Sponsor \| Dr. Gregory Sorensen
Related Party Transaction [Line Items]
Number of shares transferred (in shares)			30,000

XML 36 R25.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Private Placement Warrants (Details) - USD ($) $ / shares in Units, $ in Millions	9 Months Ended
	Sep. 30, 2020	Mar. 13, 2020
Class A common stock
Related Party Transaction [Line Items]
Number of shares issuable per warrant (in shares)		1
Exercise price of warrants (in dollars per share)		$ 11.50
Private Placement
Related Party Transaction [Line Items]
Number of warrants to purchase shares issued (in shares)	3,733,334
Price of warrants (in dollars per share)	$ 1.50
Proceeds from issuance of warrants	$ 5.6
Private Placement \| Class A common stock
Related Party Transaction [Line Items]
Number of shares issuable per warrant (in shares)	1
Exercise price of warrants (in dollars per share)	$ 11.50

XML 37 R26.htm IDEA: XBRL DOCUMENT

Related Party Transaction - Other Transactions (Details) - USD ($)		3 Months Ended	9 Months Ended
	Mar. 13, 2020	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2019
Related Party Transaction [Line Items]
Proceeds received from note payable to related party			$ 200,000
Accrued expenses - related parties		$ 17,500	17,500
Sponsor Loans
Related Party Transaction [Line Items]
Proceeds received from note payable to related party	$ 200,000
Sponsor Loans \| Maximum
Related Party Transaction [Line Items]
Amounts of transaction			200,000
Administrative Services Agreement
Related Party Transaction [Line Items]
Expenses per month			10,000
Total expenses incurred		30,000	70,000
Accrued expenses - related parties		10,000	10,000	$ 0
Wolfe Strategic Services Agreement
Related Party Transaction [Line Items]
Expenses per month			7,500
Total expenses incurred		22,500	52,500
Accrued expenses - related parties		$ 7,500	7,500	$ 0
Working Capital Loans
Related Party Transaction [Line Items]
Proceeds received from note payable to related party			$ 0
Price of warrants (in dollars per share)		$ 1.50	$ 1.50
Working Capital Loans \| Maximum
Related Party Transaction [Line Items]
Loans convertible into warrants		$ 1,100,000	$ 1,100,000

XML 38 R27.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details) - USD ($)		9 Months Ended
Commitments and Contingencies (Details) - USD ($)	Mar. 13, 2020	Sep. 30, 2020
Subsidiary, Sale of Stock [Line Items]
Underwriting discount (as a percent)		2.00%
Underwriting discount paid		$ 3,600,000
Deferred Underwriting Fees, Percentage		3.50%
Deferred underwriting fees		$ 6,300,000
Over-allotment
Subsidiary, Sale of Stock [Line Items]
Overallotment option period		45 days
Additional units issued	3,000,000

XML 39 R28.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Common Stock (Details) - $ / shares			9 Months Ended
	Feb. 19, 2020	Dec. 30, 2019	Sep. 30, 2020	Mar. 13, 2020	Dec. 31, 2019
Class of Stock [Line Items]
Common shares, shares outstanding (in shares)			5,750,000		5,750,000
Class A common stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)			100,000,000		100,000,000
Common shares, par value (in dollars per share)			$ 0.0001	$ 0.0001	$ 0.0001
Common shares, issued including shares subject to possible redemption			23,000,000
Common shares, shares issued (in shares)			1,010,128		0
Common shares, outstanding including shares subject to possible redemption			23,000,000
Common shares, shares outstanding (in shares)			1,010,128		0
Common stock, shares subject to possible redemption			21,989,872		0
Number of common stock issuable pursuant to Initial Business Combination, as a percent of outstanding shares			20.00%
Class B common stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)			10,000,000		10,000,000
Common shares, par value (in dollars per share)			$ 0.0001		$ 0.0001
Common shares, shares issued (in shares)			5,750,000		5,750,000
Common shares, shares outstanding (in shares)			5,750,000		5,750,000
Common shares, votes per share			$ 1
Total number of shares after stock split (in shares)	5,750,000
Number of shares subject to forfeiture (in shares)	750,000
Beneficial ownership (as a percent)			20.00%
Number of Class A common stock issued upon conversion of each share (in shares)			1
Class B common stock \| Sponsor
Class of Stock [Line Items]
Number of shares issued (in shares)		4,312,500
Number of shares held after stock split (in shares)	5,360,000

XML 40 R29.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Preferred Stock (Details) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Stockholders Equity
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred shares, par value	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

XML 41 R30.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Warrants (Details)	9 Months Ended
Stockholders' Equity - Warrants (Details)	Sep. 30, 2020 USD ($) $ / shares
Class of Warrant or Right [Line Items]
Public Warrants exercisable term after the completion of a business combination	30 days
Public Warrants exercisable term from the closing of the public offering	12 months
Threshold maximum period for filing registration statement after business combination	15 days
Public Warrants expiration term	5 years
Redemption price per public warrant (in dollars per share)	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days
Redemption of warrants commencing ninety days after the warrants become exercisable
Class of Warrant or Right [Line Items]
Redemption price per public warrant (in dollars per share)	$ 0.10
Minimum threshold written notice period for redemption of public warrants	30 days
Redemption period after the public warrants become exercisable	90 days
Private Placement Warrants
Class of Warrant or Right [Line Items]
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days
Class A common stock
Class of Warrant or Right [Line Items]
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days
Stock price trigger for redemption of public warrants (in dollars per share)	$ 18.00
Threshold trading days for redemption of public warrants	20 days
Threshold consecutive trading days for redemption of public warrants	30 days
Number of trading days on which fair market value of shares is reported \| $	10
Class A common stock \| Redemption of warrants commencing ninety days after the warrants become exercisable
Class of Warrant or Right [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share)	$ 10.00

XML 42 R31.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details)	9 Months Ended
Fair Value Measurements (Details)	Sep. 30, 2020 USD ($)
Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in Trust Account	$ 230,194,901
Quoted Prices in Active Markets (Level 1) \| U.S. Treasury Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in Trust Account	230,173,491
Quoted Prices in Active Markets (Level 1) \| Cash and Cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in Trust Account	21,410
Measured on a recurring basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value assets level 1 to level 2 transfers	0
Fair value assets level 2 to level 1 transfers	0
Fair value assets transferred into (out of) level 3	$ 0

EXCEL 43 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 44 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 45 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 46 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 88 262 1 false 30 0 false 4 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.dfbhealthcare.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONDENSED BALANCE SHEETS Sheet http://www.dfbhealthcare.com/role/StatementCondensedBalanceSheets CONDENSED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://www.dfbhealthcare.com/role/StatementCondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS Sheet http://www.dfbhealthcare.com/role/StatementCondensedStatementsOfOperations CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00300 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.dfbhealthcare.com/role/StatementCondensedStatementOfChangesInStockholdersEquity CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 00400 - Statement - CONDENSED STATEMENT OF CASH FLOWS Sheet http://www.dfbhealthcare.com/role/StatementCondensedStatementOfCashFlows CONDENSED STATEMENT OF CASH FLOWS Statements 6 false false R7.htm 10101 - Disclosure - Organization, Business Operations and Basis of Presentation Sheet http://www.dfbhealthcare.com/role/DisclosureOrganizationBusinessOperationsAndBasisOfPresentation Organization, Business Operations and Basis of Presentation Notes 7 false false R8.htm 10201 - Disclosure - Significant Accounting Policies Sheet http://www.dfbhealthcare.com/role/DisclosureSignificantAccountingPolicies Significant Accounting Policies Notes 8 false false R9.htm 10301 - Disclosure - Initial Public Offering Sheet http://www.dfbhealthcare.com/role/DisclosureInitialPublicOffering Initial Public Offering Notes 9 false false R10.htm 10401 - Disclosure - Related Party Transactions Sheet http://www.dfbhealthcare.com/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 10 false false R11.htm 10501 - Disclosure - Commitments and Contingencies Sheet http://www.dfbhealthcare.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 11 false false R12.htm 10601 - Disclosure - Stockholders' Equity Sheet http://www.dfbhealthcare.com/role/DisclosureStockholdersEquity Stockholders' Equity Notes 12 false false R13.htm 10701 - Disclosure - Fair Value Measurements Sheet http://www.dfbhealthcare.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 13 false false R14.htm 10801 - Disclosure - Subsequent Events Sheet http://www.dfbhealthcare.com/role/DisclosureSubsequentEvents Subsequent Events Notes 14 false false R15.htm 20202 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.dfbhealthcare.com/role/DisclosureSignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.dfbhealthcare.com/role/DisclosureSignificantAccountingPolicies 15 false false R16.htm 30703 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.dfbhealthcare.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.dfbhealthcare.com/role/DisclosureFairValueMeasurements 16 false false R17.htm 40101 - Disclosure - Organization, Business Operations and Basis of Presentation - Financing (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureOrganizationBusinessOperationsAndBasisOfPresentationFinancingDetails Organization, Business Operations and Basis of Presentation - Financing (Details) Details http://www.dfbhealthcare.com/role/DisclosureOrganizationBusinessOperationsAndBasisOfPresentation 17 false false R18.htm 40102 - Disclosure - Organization, Business Operations and Basis of Presentation - Trust Account (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureOrganizationBusinessOperationsAndBasisOfPresentationTrustAccountDetails Organization, Business Operations and Basis of Presentation - Trust Account (Details) Details 18 false false R19.htm 40103 - Disclosure - Organization, Business Operations and Basis of Presentation - Liquidity (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureOrganizationBusinessOperationsAndBasisOfPresentationLiquidityDetails Organization, Business Operations and Basis of Presentation - Liquidity (Details) Details http://www.dfbhealthcare.com/role/DisclosureOrganizationBusinessOperationsAndBasisOfPresentation 19 false false R20.htm 40201 - Disclosure - Significant Accounting Policies - Concentration of Credit Risk, Cash and Cash Equivalents and Class A common stock subject to possible redemption (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureSignificantAccountingPoliciesConcentrationOfCreditRiskCashAndCashEquivalentsAndClassCommonStockSubjectToPossibleRedemptionDetails Significant Accounting Policies - Concentration of Credit Risk, Cash and Cash Equivalents and Class A common stock subject to possible redemption (Details) Details 20 false false R21.htm 40202 - Disclosure - Significant Accounting Policies - Net Loss Per Share of Common Stock (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureSignificantAccountingPoliciesNetLossPerShareOfCommonStockDetails Significant Accounting Policies - Net Loss Per Share of Common Stock (Details) Details 21 false false R22.htm 40203 - Disclosure - Significant Accounting Policies - Income Taxes (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureSignificantAccountingPoliciesIncomeTaxesDetails Significant Accounting Policies - Income Taxes (Details) Details 22 false false R23.htm 40301 - Disclosure - Initial Public Offering (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureInitialPublicOfferingDetails Initial Public Offering (Details) Details http://www.dfbhealthcare.com/role/DisclosureInitialPublicOffering 23 false false R24.htm 40401 - Disclosure - Related Party Transactions - Founder Shares (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails Related Party Transactions - Founder Shares (Details) Details 24 false false R25.htm 40402 - Disclosure - Related Party Transactions - Private Placement Warrants (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureRelatedPartyTransactionsPrivatePlacementWarrantsDetails Related Party Transactions - Private Placement Warrants (Details) Details 25 false false R26.htm 40403 - Disclosure - Related Party Transaction - Other Transactions (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureRelatedPartyTransactionOtherTransactionsDetails Related Party Transaction - Other Transactions (Details) Details 26 false false R27.htm 40501 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.dfbhealthcare.com/role/DisclosureCommitmentsAndContingencies 27 false false R28.htm 40601 - Disclosure - Stockholders' Equity - Common Stock (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureStockholdersEquityCommonStockDetails Stockholders' Equity - Common Stock (Details) Details 28 false false R29.htm 40602 - Disclosure - Stockholders' Equity - Preferred Stock (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureStockholdersEquityPreferredStockDetails Stockholders' Equity - Preferred Stock (Details) Details 29 false false R30.htm 40603 - Disclosure - Stockholders' Equity - Warrants (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureStockholdersEquityWarrantsDetails Stockholders' Equity - Warrants (Details) Details 30 false false R31.htm 40701 - Disclosure - Fair Value Measurements (Details) Sheet http://www.dfbhealthcare.com/role/DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.dfbhealthcare.com/role/DisclosureFairValueMeasurementsTables 31 false false All Reports Book All Reports dfphu-20200930.xml dfphu-20200930.xsd dfphu-20200930_cal.xml dfphu-20200930_def.xml dfphu-20200930_lab.xml dfphu-20200930_pre.xml http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 true true ZIP 48 0001104659-20-125040-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-20-125040-xbrl.zip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end